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ABSTRACT
This thesis describes the use of non-invasive ultrasound in assessing 
the cardiovascular system. Ultrasound is one of the most widely used 
imaging techniques in clinical medicine and recent advances suggest 
an even greater potential. New developments in ultrasound technology 
include higher image resolution and faster computer processing.
Echocardiography is routinely available in clinical practice and can be 
used to measure both cardiac structure and function. This well 
validated technique is applied to an original study of hypertension 
where measures of left ventricular diastolic function are found to 
support a change in the management of white coat hypertension.
Arterial mechanical function can now be studied non-invasively 
allowing assessment of arterial compliance by measuring small 
changes in arterial diameter throughout the cardiac cycle. In addition 
the tensile stress applied during cardiac contraction can be estimated by 
measuring systolic and diastolic flow velocities within the vessel. The 
new technique of arterial wall tracking is described and compared to 
conventional Doppler examination of the arteries.
High resolution ultrasound can provide enough detail to measure the 
separate layers within arterial walls with a resolution of 0.01mm. This 
technique is used in a study of atherosclerosis and hypertension where 
measurements of early atherosclerosis (intima-medial thickness) are 
compared to plasma markers including lipoprotein (a) and fibrinogen.
Computer analysis of Doppler waveforms allows digital visual 
representation of blood flow. The fast Fourier transformation technique 
is used in transcranial Doppler ultrasound where low MHz frequency 
ultrasound is used to penetrate bone allowing monitoring of 
intracranial blood flow velocities. Continuous digital monitoring of 
arterial blood flow revealed signals caused by circulating microemboli 
in subjects with carotid artery stenosis. Transcranial Doppler 
ultrasound is used in this thesis to study commercial air divers and 
subjects with carotid atherosclerosis. These disparate groups represent 
sources of gaseous and solid emboli respectively.
Overall the thesis describes the original use of established and new 
ultrasound techniques which are applicable to clinical practice.
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CHAPTER 1 INTRODUCTION
This MD thesis describes the application of non-invasive ultrasound 
techniques in the assessment of cardiovascular structure and function. 
It is intended to demonstrate the clinical versatility of ultrasound in 
cardiovascular medicine by describing techniques that can be used to 
measure left ventricular wall thickness and contractility, arterial wall 
thickness and compliance, atherosclerotic severity, and to detect 
signals caused by circulating emboli.
In terms of end points, there are effective forms of treatment for many 
aspects of cardiovascular disease but the potentially reversible benefits 
decrease as the disease progresses. For example, young healthy 
arteries have adaptive mechanisms which compensate for reduced 
blood flow, and age or disease related gradual functional and structural 
deterioration may only become clinically apparent in middle or old 
age. In addition the eventual clinical presentation may be irreversible 
whereas early intervention might have retarded or prevented the 
progression. The key issue therefore is to identify high risk individuals 
at an early stage. Non-invasive techniques are required which are 
capable of screening large numbers of individuals with high levels of 
specificity and sensitivity but with low risk of potential side effects. 
Ultrasound is such a technique. There have been no clinically
1
significant side effects from ultrasound energy used in medical 
• * 1 2imaging. ’ Although high energy ultrasound can cause small gas 
bubble formation in vitro this does not occur with the energy levels 
used in clinical practice.2 This inexpensive technique can be used 
safely to study asymptomatic individuals and to improve patient 
selection for treatment or further investigation. This thesis describes 
how ultrasound has evolved into specialised techniques that are 
capable of measuring both structure and function. The thesis is 
arranged in anatomical order; starting with cardiac studies (Chapter 5) 
before assessing the mechanical properties of large arteries (Chapters 
6 and 7), measuring arterial structure (Chapter 8) and finally 
describing signals caused by circulating emboli (Chapters 9 and 10).
1. Echocardiography
The first study describes echocardiographic assessment of cardiac 
function and structure in hypertension. Echocardiographic 
measurement of left ventricular structure is widely available and has 
been validated extensively with invasive measurements and post 
mortem studies. ' The Framingham cohort follow-up study is an 
example of a population based screening programme where ultrasound 
was used to estimate left ventricular mass. This subsequently was
2
shown to be an important prognostic marker of cardiovascular 
mortality.6'8
In addition, echocardiography can be used to measure the velocity of 
blood travelling within the cardiac chambers by Doppler ultrasound. It 
is possible, for example, to measure the flow of blood through the 
mitral valve during left ventricular filling to determine ventricular 
compliance during relaxation.9 The ventricle normally fills by energy 
dependent active relaxation which effectively drains most of the blood 
contained in the atrium by suction. The left atrium then contracts to 
complete the small remainder of ventricular filling. However, in 
hypertension the ventricle is less compliant and relaxes inadequately 
thus requiring proportionally more active atrial filling.10 This 
impairment of filling can be measured objectively by the E:A ratio 
(see figure 1) which is determined by the ratio of Early (passive) 
filling related to Active (atrial) filling. This is described in detail in 
chapters 4 and 5. This is clinically relevant since left ventricular 
diastolic dysfunction can be detected early in disease processes such as 
hypertension and may precede symptomatic left ventricular systolic 
dysfunction.
The aim of the study was to measure parameters of structure and 
function in subjects who remained hypertensive throughout an 
ambulatory blood pressure monitoring period (persistent 
hypertensives).
APulse wave Doppler sample
ventricle during diastole
Normal diastolic 
function with Early 
filling contributing 
most of ventricular 
filling and Atrial 
filling serving to top- 
up the ventricle
Abnormal diastolic 
filling with a reduction 
in Early relaxation and 
an increase in Atrial 
contraction. This 
reversal of the E:A 
pattern is common in 
hypertension.
Figure 1. Echocardiographic measurement of diastolic function.
E:A ratio >1
E:A ratio <1
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and to compare the findings with matched groups of normotensive and 
white coat hypertensives. White coat hypertensives by definition were 
normotensive after leaving the hospital but were significantly 
hypertensive within a clinical setting. The groups were matched for 
body characteristics such as weight, height, sex and age which can 
affect the pattern of ventricular filling. The aim was to determine if 
white coat hypertensives had objective evidence of cardiac 
dysfunction which could benefit from antihypertensive treatment.
2. Arterial compliance
The next study describes the measurement of arterial compliance in 
the same patient groups. This involves a relatively new ultrasound 
technique to detect arterial diameter changes throughout the cardiac 
cycle. The principles involved in describing mechanical properties of 
arteries are described in detail in chapter 2 and the use of wall tracking 
ultrasound in hypertension is reviewed. This involves very high 
resolution Doppler ultrasound to track the movement of the arterial 
walls (wall tracking technique) and gives a measure of the mechanical 
properties of the artery which can change in disease processes such as 
atherosclerosis and hypertension. The large arteries act as an elastic 
buffer during cardiac contraction and help to smooth the pulsatile flow 
of blood to the periphery.11'15 They absorb reflected pressure waves
5
i  *y
caused by peripheral resistance during cardiac contraction. With 
increasing age this buffering capacity decreases because of changes in 
the mechanical properties and load bearing capacity of the vessels.
• 1 0  1 f\ 0 0Studies of the large arteries in hypertension * ' have shown that 
these functional abnormalities may be reversible with treatment. These 
include abnormalities of arterial diameter, distension, elasticity and 
compliance which are implicated in the progression of atherosclerosis 
and failure of the elastin portion of the arterial wall. This is thought to
be a major factor in the development of systolic hypertension in the
12 • *elderly and is also involved in the pathogenesis of aneurysm
formation. Ultrasound measurement of vascular dysfunction allows 
calculations of derived parameters which describe arterial function 
while correcting for arterial size, wall thickness or blood pressure at 
the time of measurement. These are discussed in detail in a review of 
arterial compliance measurement (chapter 2). The wall tracking 
technique is applied to the patients described in chapter 5 with 
additional comparisons between vascular mechanical properties and 
cardiac structure and function. Having identified functional cardiac 
abnormalities in the white coat hypertensive patients the next step was 
to look for similar vascular abnormalities. Hypertension may initially 
cause peripheral vascular dysfunction (eg vasoconstriction, or
6
mechanical damage through repetitive strain) before secondary cardiac 
dysfunction.
An alternative approach to the wall tracking technique of vascular 
mechanical stress measurement is described in a study of carotid 
arterial pulsatility in hypertension (chapter 7). This study explores the 
relation between hypertension and mechanical stress in the large 
arteries leading to the cerebral circulation. Using the wall tracking 
technique described above it is possible to measure parietal stress, a 
measure which describes the stretching force within an artery based on 
the distending pressure, radius of the vessel and wall thickness. The 
pulsatility index also reflects mechanical stress and is based on the 
speed of blood travelling within the artery. This can be measured using 
pulsed wave Doppler ultrasound (as described in chapters 4 and 7). 
These measurements are performed in groups of normotensive and 
hypertensive patients and are used to investigate the changing pattern 
of stroke incidence world-wide following the introduction of 
antihypertensive therapy which has resulted in a greater reduction in 
haemorrhagic compared to atherosclerotic stroke.
3. Vascular structure
High resolution ultrasound can be used to measure arterial wall 
thickness with axial resolution approaching 200pm (as described in
7
chapter 4). This technique is used in an extension of the study of white 
coat hypertensives to describe measurements of common carotid 
arterial intima-medial thickness (IMT) in relation to blood pressure 
patterns. There is increasing evidence that large vessel IMT may be an 
important predictor of cardiovascular disease and can reflect the 
severity of arterial disease elsewhere in the body including the 
coronary arteries which are still inaccessible to non-invasive 
ultrasound imaging.
High resolution B-mode ultrasound provides anatomical images of 
tissues allowing measurements of arterial wall thickness that have 
been shown to correlate well with surgical and post-mortem 
specimens of carotid arteries.21'23 It is important to study arterial wall 
structure rather than lumen diameter (eg measurement of stenosis by 
invasive angiography) since arteries enlarge outwards in the early 
stages of atherosclerosis without any decrease in luminal diameter. 
This is explored in chapter 8 where the effect of persistent and white 
coat hypertension on carotid wall thickness is compared to 
normotensive subjects as a measure of end organ damage. While 
chapters 5 and 6 show functional abnormalities in the white coat 
hypertensives, this study shows mild structural changes in the large 
arteries. The clinical implications are discussed in detail.
8
4. Circulating embolus detection
The final technique used in this thesis describes ultrasound 
measurement of the properties of the blood carried within the arteries. 
One of the first uses of ultrasound in medicine was as a safety alarm 
warning of gas emboli in bypass circuits. The technique of embolus 
detection has since developed and was used initially to refine 
decompression tables for sub-aqua divers but now is used in clinical 
practice as transcranial Doppler ultrasound (TCD).
TCD embolus detection has developed as a separate technique 
following a study which used ultrasound to monitor the cerebral 
circulation of patients undergoing carotid artery surgery. Abnormal 
intermittent high intensity, short duration embolic signals were 
detected during the surgical procedure particularly during cross clamp 
release.27'29 These signals were thought to result from small blood 
clots or air bubbles introduced during the procedure. Two distinct 
patterns of embolic signals have emerged in TCD research. Gas 
emboli cause intense reflectance of ultrasound energy and 
correspondingly show as high amplitude signals compared to a solid 
embolus of a similar size. This is discussed in a review of the clinical 
studies using TCD embolus detection (chapter 3).
9
Chapter 9 describes TCD ultrasound monitoring of commercial divers 
during decompression and was the first published use of TCD in 
divers, using the technique as a non-invasive screening test for right- 
to-left intracardiac shunting through a patent foramen ovale and then 
monitoring the arterial circulation during decompression. The TCD 
shunt detection technique is compared to contrast transthoracic 
echocardiography.
The second TCD study (Chapter 10) is of embolus detection in carotid 
atherosclerosis, a setting associated with solid circulating
•  • TO T ^microemboli. ' Patients with stenosis of the internal carotid artery 
are at risk of embolic stroke. However, only a minority ever become 
symptomatic ’ and there is as yet no reliable way of identifying the 
high risk individuals. The aim of this study was to establish if 
circulating signals were present in subjects with atherosclerotic plaque 
but without significant haemodynamic disturbance of blood flow. This 
is important if TCD is to become clinically useful. In addition the 
results help to explain the origin of the signals in atherosclerosis, and 
evidence is presented which supports turbulent blood flow as a cause 
of microembolic signals formation.
10
CHAPTER 2 VASCULAR COMPLIANCE
1. Introduction
Measurement of arterial compliance in vivo allows greater insight into 
the pathogenesis of hypertension and enables an objective approach to 
treatment. The measurement techniques are also applicable to other 
clinical settings such as cardiac failure 13,38‘9 and hyperlipidaemia40*42 
where arterial function may be disturbed.
2. Arterial compliance
The large arteries act as an elastic buffer to help smooth the pulsatile 
delivery of blood from the left ventricle and thereby provide almost 
continuous flow through the peripheral arterioles and capillaries.43 
Various models have been used to describe this flow pattern and one of 
the earliest was the Windkessel which first was described by Stephen 
Hales in 1769. The Windkessel was the air filled dome in early fire 
engines which acted as a cushion to absorb fluctuations in water 
pressure delivered to the engine reservoir, thus allowing a smooth 
delivery of water to the fire hose (see figure 2). The physiological 
analogy is obvious with the pulsatile pump representing the heart, the 
Windkessel the elastic arteries and the fire hose as the peripheral
11
Windkessel 
(air cushion)
water
reservoir Fire
hose
Pump
water
BLOOD- HEART ELASTIC.
ARTERIES
.PERIPHERAL
RESISTANCE
Figure 2. Windkessel model of arterial compliance.
Adapted from O’Rourke MF, Brunner HR. J Hyperten 1992;10(S6):S3-S5
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resistance. However, this model assumes that the arterial circulation is 
uniform but in vivo this is not the case. Larger vessels, such as the 
aorta and carotid arteries, differ in compliance and elasticity to smaller, 
more muscular arteries such as the brachial and radial vessels.44 In 
addition arterial compliance varies along the length of arteries, 
particularly around junctions, curves and bifurcations.44,45 The relative 
proportions of elastin, collagen and muscle fibres in the arterial wall 
determine the buffering capacity of the artery. Dynamic changes in 
compliance due to arterial constriction or dilation resulting from 
changes in sympathetic tone also need to be considered when 
measuring arterial function.
Interest in arterial compliance started last century before the 
development of manometers for measuring blood pressure. It was 
noted that some patients had palpable abnormalities of radial, brachial 
or carotid arterial pulsation.46 The pressure required to obliterate the 
pulse was estimated by hand and the notches in the pulse waveforms 
were also recognised. Age related changes were also described at this 
time with the elderly having stiffer arterial walls.47 Early descriptions 
of hypertension therefore were based on systolic pressure since this 
corresponded to the manual effort required to overcome an arterial 
pulse. However, following the development of the manometer, there 
was increased recognition of diastolic blood pressure which was
13
thought to be related to peripheral resistance and arteriolar tone, 
whereas systolic pressure was thought to be a measure of cardiac 
function. Results from large prospective studies such as the 
Framingham cohort49'52 follow-up, Systolic Hypertension in the 
Elderly Program53 (SHEP), and Multiple Risk Factor Intervention Trial 
(MRFIT)54 relate systolic rather than diastolic pressure to target organ 
damage including left ventricular hypertrophy, as well as mortality 
from cardiac and cerebrovascular causes.
A major determinant of systolic blood pressure is the stiffness of the
i
large arteries. Stiffer, less compliant arteries cause an increase in 
systolic pressure because of the lack of elastic buffering effect during 
left ventricular contraction.55 In addition, reflected pressure waves 
return earlier from the periphery thereby increasing the systemic
c/r cn
systolic pressure and left ventricular load. ’ In normotensive subjects 
these reflected waves return during early diastole when the left 
ventricle is relaxing (see figure 3). Arterial stiffness in turn is 
dependent on the relative proportions of elastin and collagen within the 
arterial wall.43 The elastin fibres become disorganised with increasing 
age and may fragment leading to a compensatory increase in the
r  f t
collagen component. This degeneration may result from repeated 
mechanical stress during left ventricular contraction as well as a 
decrease in the blood supply to the vessel wall through the vasa 
vasorum.12
<L>
t-H
C/3
time
Figure 3. Effect of hypertension on aortic pressure waveform.
This is a diagrammatic representation of ascending aortic pressure 
tracings taken in a hypertensive subject (top) and a normotensive 
subject (bottom) showing the effects of (1) increased peripheral 
resistance, (2) decreased aortic distensibility and (3) early return of 
reflected pressure waves which now coincide with peak systolic 
pressure rather than occurring in early diastole.
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Consequently the arteries become stiffer and increase in diameter and 
length.43,47,55,59 Arterial wall thickness as measured by ultrasound in 
vivo also increases in proportion to systolic pressure.60 These changes 
result in an increase in systolic blood pressure which in itself will 
accelerate the degenerative process through increased mechanical 
cyclic strain.
The pressure-diameter relationship in physiological conditions is 
essentially curved.61 This is because at lower pressures elastin fibres 
alone are sufficient to restrict the arterial distension. However at 
higher pressures the collagen fibres are progressively recruited 
resulting in a decrease in distensibility per unit of pressure increase, 
thus the artery becomes stiffer as it is dilated. Muscular tone alters the 
ratio of elastin and collagen fibres which are used and this also affects 
arterial compliance. The smooth muscle fibres in the arterial wall are 
aligned in series with the collagen strands and in parallel with the 
elastin. When the muscle fibres contract this transfers the load bearing 
component to the collagen fibres and causes the artery to stiffen during 
vasoconstriction.61,62
3. Ultrasound measurement techniques
There are two main approaches to the non-invasive assessment of 
arterial compliance in vivo. Early studies described ultrasound
16
measurement of pulse wave velocity whereas more recent advances in 
high resolution ultrasound have allowed continuous measurement of 
dynamic changes in arterial diameter during cardiac contraction.
The pulse wave velocity is calculated by measuring the delay in the 
start of the pulse pressure wave between two points in the arterial 
circulation. Dividing the distance between the two measuring sites by 
the time difference allows the pulse wave velocity to be estimated, and 
this is usually in the range of 500 to 2000 cm/second. This can be used 
to assess arterial compliance by calculating Young’s modulus which is 
a measure of arterial elasticity described in 1807 by Thomas Young 
(as discussed recently in an editorial ). It was defined at that time as 
“The modulus of elasticity of any substance is a column of the same 
substance, capable of producing a pressure on its base which is to the 
weight causing a certain degree of compression as the length of the 
substance to the diminution of its length”. This was applied to human 
physiology in 1826 by the French mathematician Navier by using 
Young’s modulus as a measure of arterial stiffness which controls for 
vessel wall thickness and includes pulse pressure in its determination 
(see below for equations). The Moens Kortewig equation allows 
Young’s elastic modulus to be calculated from pulse wave velocity 
(PWV):
17
PWV =
2r • p
E • h Units: cm/second
where E is Young’s elastic modulus, h is arterial wall thickness, r is 
internal radius and p is the density of blood. Blood density is normally 
around 1.05 g/ml and this is often approximated to 1 to simplify the 
calculation.
In addition arterial distensibility can be indirectly estimated according 
to the Bramwell and Hill formula as 3.57 / PWV.
There are limitations with this approach, in particular the assumption 
that arterial segments are uniform in behaviour, which certainly is not 
the case in vivo.44,45 The pulse wave velocity measures the global 
rigidity of an arterial segment. However, continuous measurement of 
arterial diameter during the cardiac cycle allows the calculation of 
local arterial distensibility, which is essential if the localised nature of 
atherosclerosis is to be considered.
The first description of this technique was by Arndt64 in 1968 using 
pulsed wave ultrasound. He developed a device which detected 
reflected ultrasound energy from arterial walls and allowed 
measurement of the arterial diameter during the cardiac cycle. There 
have been great advances in technology since then and modem devices
18
have much improved reproducibility and resolution. Most link to 
conventional ultrasound imaging machines used in clinical practice 
and allow the operator to visualise the appropriate artery before 
analysing its function using a wall tracking device. This can track the 
interfaces of the anterior and posterior walls with much higher 
resolution than is visible on the television monitor. Theoretically it is 
possible to measure to a resolution of 2 pm in the latest machines,65 
but in vivo results tend to be less precise because of biological 
variability, and a resolution of 75 pm has still to be exceeded. This 
reflects assumptions which are made of the velocity of ultrasound 
energy through the connective tissue and blood. Although this varies 
according to the tissue density most manufacturers use the velocity of 
sound through blood at 37°C as a compromise. This requires that 
measuring sessions are performed in strictly temperature controlled 
environments and that patient surroundings are also standardised to 
minimise between visit variability.
Wall tracking devices allow measurement of changes in arterial 
diameter throughout the cardiac cycle. From these measurements 
parameters can be calculated which describe arterial stiffness, 
distensibility, elasticity, and compliance and which can allow for 
confounding factors such as the blood pressure at the time of 
measurement or the thickness of arterial wall. These calculations are
19
described in detail below. This thesis includes the evaluation of 
patients with a wall tracking device rather than measurement of pulse 
wave velocity, so particular emphasis has been placed on the 
parameters which are available from such devices.
4. Compliance calculations from  wall tracking data
Fractional distensibility can be calculated if the minimum arterial 
diameter and maximum distension are known:
Fractional distensibility = Ds - Dd No units
Dd
where Ds is the systolic (maximum) diameter and Dd is the diastolic 
(minimum) diameter. This measure of distensibility can be used to 
calculate the pressure-strain elastic modulus66 (Peterson modulus, E p):
Ep = Pulse pressure Units: kPa
Fractional distensibility
This parameter includes blood pressure as a determinant and is 
dependent on the filling pressure at the time of measurement. This can 
be a confounding factor, for example when comparing groups of 
patients with differing levels of blood pressure. The stiffness index is 
considered to be relatively independent of blood pressure44,38 and is
20
calculated as the natural logarithm of the ratio of systolic to diastolic 
pressure divided by the fractional distensibility:
Stiffness index = In rSystolic / Diastolicl No units
Fractional distensibility
Young’s elastic modulus (E) measures stiffness but controls for 
arterial wall thickness, an important consideration if the duration of 
hypertension is not known or is known to be different in the groups 
being compared.
E = R x Pulse pressure Units: kPa
IMT Fractional distensibility
where R  is the outer radius of the artery, and I M T  is the intima plus 
medial thickness.
These parameters measure different aspects of arterial elasticity. As 
arteries become stiffer the compliance decreases and the stiffness 
index, Ep and E increase.
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5. Wall tracking Doppler ultrasound technology
The first use of wall tracking technology was described in 1968 when 
M (motion) mode ultrasound was used to determine carotid arterial 
diameter.64 Technology has advanced considerably and the first study 
using Doppler ultrasound was described in 1985 by Hoeks et al.67 
Significant limitations were present with the technology available at 
that time, particularly since it was necessary to sample ultrasound 
reflectance within a tightly controlled sample volume. In addition, 
measurements could not be performed on-line.
♦ roAn A (amplitude) mode Doppler device was developed in 1990 
which allowed the user to select the segment of artery to be studied 
using a cursor in a B (brightness) mode image. The various ultrasound 
modes are described in chapter 4. M-mode ultrasound was used to 
measure arterial diameter changes in that segment and radiofrequency 
signal analysis of the changes in arterial wall motion were transferred 
to computer for analysis. This technology has continued to develop but 
the basic principles remain unchanged. The most highly developed 
wall tracking device to date is the NIUS 02 high resolution Doppler 
angiometer69 (Capital Medical Services, Paris) which uses a 10 MHz 
probe contained within a stereotactic positioning arm. This device can 
be used alone or in conjunction with a B-mode ultrasound imaging
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system. The basic mechanism of the NIUS 02 is described below. The 
ultrasound probe contains both emitter and receiver units. The emitter 
units generate up to 500 very short, high amplitude, ultrasonic pulses 
per second with frequencies up to 10 MHz and a rise time of less than 
10 ms to penetrate the tissue being studied. The receiver units detect 
reflected ultrasound energy and this is analysed at high frequency 
(over 100 MHz) by the computer. Earlier machines stored 5-10 
seconds of information in the computer memory, or on disc. The latest 
machines allow continuous real-time analysis of reflected energy, and 
also storage of much longer periods for off-line analysis. Additional 
features can include simultaneous continuous measurement of blood 
pressure (using photoplethysmographic finger cuffs) and estimation of 
blood flow using Doppler ultrasound.
Much of the research published to date in hypertension has used the 
earlier versions of the NIUS. This is summarised below.
6. Abnormalities o f  vascular function in hypertension
Early research using wall tracking technology demonstrated potential 
limitations with the technique. Far from being static, compliance in 
both the elastic and muscular arteries varies in individuals. Diurnal 
variation of carotid arterial diameter and compliance has been 
demonstrated in a small study of 12 healthy men70 where small but
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significant increases in carotid arterial diameter were found at night. 
The brachial artery was also studied but the differences were not found 
to be statistically significant. Such diurnal variation is unlikely to be 
troublesome in research if subjects are studied at similar times each 
session. However, short term spontaneous diameter oscillations have 
been found to be present in the radial artery71 with cycle frequencies of 
45-70 seconds. This results in significant changes in both arterial 
diameter and compliance and is thought to result from intrinsic muscle 
cell activity rather than sympathetic stimulation. Such changes are 
more difficult to compensate for and research continues to try to 
identify a suitable technique of analysis.
That arterial compliance is altered early in disease states, and thus may 
potentially be used as an early marker of future cardiovascular disease, 
is suggested by the finding of early vascular structural changes in the
79offspring of hypertensive patients. This suggests a loss of elasticity 
and compliance in the peripheral vasculature similar to the cardiac 
abnormalities found in a study of diastolic left ventricular function 
using an analogous cohort of parents and offspring.
The common carotid artery is most often used in studies of arterial 
compliance because of ease of access and because its relatively large 
size allows more accurate measurement of diameter. Such work has 
shown increased vessel stiffness in both treated and untreated
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subjects.16,74'76 Carotid wall compliance decreases both with ageing 
and increasing blood pressure,77 and is associated with the 
development of left ventricular hypertrophy.74,76
Local variations of arterial compliance have been found in small 
sections of the carotid artery in hypertensives45 consistent with the 
focal effects of both hypertensive vascular damage and atherosclerosis. 
This is a strong argument for the use of wall tracking equipment to 
measure compliance in one section of an artery (most often the distal 
common carotid artery proximal to the bulb) to allow meaningful 
comparisons to be made between groups, rather than pulse wave 
velocity measurements which reflect the mechanics of an entire 
arterial segment.
Recently it has become possible to study smaller arteries such as the 
radial and brachial vessels and with the latest technology vessels as 
small as the digital arteries can be examined, as well as measurements 
of vascular compliance in small laboratory animals.
One interesting paradox apparent from research involving smaller 
arteries has been the finding of an increase in radial artery isobaric
no 7Q
compliance in patients with essential hypertension. ’ Although this 
at first seems surprising, it may in part explain why the radial artery 
usually is found to be atheroma free (and thus suitable for coronary 
artery bypass grafting as an alternative to the internal thoracic artery).
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It also contrasts with the results from plethysmographic studies of
ftO ft 1forearm vascular resistance, ’ although these results are influenced 
more by arteriolar rather than small arterial tone. In addition, many of 
the previous studies of conduit artery compliance were based on pulse 
wave velocity which includes brachial or in some cases aortic 
compliance rather than local measurements of the radial artery.
The effects of treatment have yet to be assessed in large studies.
1 7 7 0  ft? ft? •Preliminary work ’ ’ ’ involving treatment with angiotensin 
converting enzyme (ACE) inhibitors, suggests a beneficial effect in 
terms of arterial compliance. Previous work using pulse wave velocity 
confirms the likely benefits of antihypertensive vasodilators in 
reducing arterial compliance: such studies12 included ACE inhibitors, 
calcium channel antagonists, nitroprusside and dihydralazine. 
However, beta blockers adversely affect the return of reflected 
pressure waves from the periphery and may paradoxically increase 
arterial stiffness.
In summary, accurate and reproducible measurement of arterial 
compliance is now possible with ultrasound wall tracking devices. The 
compliance parameters are influenced by arterial wall properties 
including wall thickness which, in turn, is affected by conditions 
including hypertension and atherosclerosis. The effect of treatment 
requires further investigation.
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CHAPTER 3
Transcranial Doppler embolus detection
7. Introduction
The development of transcranial Doppler ultrasound (TCD) to detect 
circulating solid and gas emboli is described in this chapter. TCD has 
been introduced to clinical applications only very recently and the 
significance of emboli signals is yet to be established. It is important to 
understand some of the basic principles involved so that the limitations 
can be appreciated and these are detailed below. TCD is applied later 
to a study of gas emboli in divers (Chapter 9), and solid emboli in 
patients with carotid atherosclerosis (Chapter 10). There are important 
differences between the embolic particles and the resultant signals 
differ greatly.
2. Historical background
The principle behind embolus detection is the Doppler frequency shift
OA
which was first described by Christian Doppler in 1842. He noted 
that the measured frequency of emitted energy varied when the source 
of energy moved in relation to the observer. This can be observed, for 
example, when sirens appear to rise in pitch when approaching an
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ultrasound where moving objects such as circulating blood cells reflect 
ultrasound energy at frequencies relative to their motion.
Doppler ultrasound first was used to detect embolic material by 
Austen in 1965 as a safety device to prevent air embolism in a 
cardiac bypass circuit. Air emboli were successfully detected and the 
technique subsequently was developed and widely used as a safety 
alarm. However the first study of human blood vessels in vivo was by
QC
Spencer in 1968 who investigated the incidence of venous gas emboli 
in decompression sickness. He developed portable battery powered 
ultrasound monitors which allowed the observer to listen to a derived 
Doppler waveform of circulating blood. It was possible with training to 
recognise the patterns of blood flow in the veins, arteries and heart as 
well as detecting signals from heart valve movement. Using this 
technique he observed high frequency signals which were distinct from 
the background waveforms and which were later shown to result from
'j/r o/* # #
gas bubbles in the venous system. ’ He monitored the subclavian 
veins, right heart and inferior vena cava. It was hoped that Doppler 
ultrasound monitoring would provide an objective measure of 
decompression risk or nitrogen gas load but unfortunately little 
correlation was found between the bubble counts in the venous system 
and the incidence or severity of decompression sickness.
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Gas emboli in motion are easy to detect because of the large difference 
in density compared to surrounding blood components. This large 
difference causes a greater reflectance of ultrasound from the interface 
of the bubble and the blood and thus a higher signal amplitude. Solid 
emboli composed of platelets or thrombus are more difficult to detect 
since there is little difference in density between the emboli and 
circulating blood which results in less intense signals. This basic 
principle is crucial to the clinical relevance of Doppler embolus 
detection.
3. Carotid surgery, angiography and angioplasty.
o 7
Conventional transcranial Doppler ultrasound is reviewed elsewhere 
but the first description of TCD embolus detection was in 1986 by 
Padayachee et al28 during carotid endarterectomy. While attempting to 
assess cerebral collateral circulation by Doppler ultrasound during 
temporary occlusion of the internal carotid artery, high amplitude 
signals suggestive of circulating emboli were detected in the middle 
cerebral arteries. They found that 17 of 19 patients had high intensity 
Doppler signals as shunting started but found no correlation with 
clinical outcome.
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97Further work by Spencer demonstrated high intensity signals 
suggestive of gas embolism in 35 of 91 patients undergoing carotid 
endarterectomy. Lower intensity signals consistent with formed 
element or solid embolism also were found in 24 of these patients. 
Embolic signals were defined as transient (lasting 0.001 to 0.1 
seconds), random in timing, and having an amplitude at least 10 dB 
greater than the background Doppler blood flow signal. Gas emboli 
were associated with the release of arterial cross clamps and typically 
had amplitudes 60 dB greater than the background signal. Formed 
element signals were less intense (10 - 40 dB greater than background) 
and were less frequent compared to gas emboli signals. They occurred 
mainly during compression of the common carotid artery during 
surgery or several hours after arteriotomy closure. Some circumstantial 
evidence was presented which suggested that the solid signals were 
more likely to be clinically significant but this was not conclusive.
Microembolic signals were detected during cerebral angiography by 
Markus et al88 in 1993. Seven patients were studied during cerebral 
angiography which was being performed to evaluate cerebrovascular 
disease or to investigate the source of subarachnoid haemorrhage.
Signals were found in the middle cerebral arteries during the injection 
of contrast into the ipsilateral internal or common carotid artery and 
these lasted for approximately 3 seconds after injection. In addition
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signals were detected during flushing of the catheter with saline. There 
was a higher rate of embolism during fast injections, and when using 
contrast medium which had not been left to stand for several minutes. 
Microscopic gas bubbles in the injection medium were the most likely 
cause of the high intensity signals. Cerebral angiography is an invasive 
procedure with associated morbidity and very occasional mortality. 
The risk of cerebral injury during angiography is approximately 4%
OQ
and the authors suggested that this may be related to air embolism. 
Similar signals were found during carotid angioplasty.90
TCD embolus detection is now used in many centres to detect and 
prevent gas embolism particularly during carotid surgery,91 as well as 
during angiography and cardiac bypass surgery.92-4 Transoesophageal 
echocardiography recently has been used to confirm gas bubbles as the 
cause of TCD embolic signals in these settings.96 This may be 
clinically important since silent gas embolism has been implicated in 
the neurological impairment seen following bypass surgery.95,97 Some 
centres use the technique post-operatively to identify solid emboli 
forming at the arteriotomy site and will re-operate if there are frequent
Q O
embolic signals during this period. The discovery of pre-operative 
solid emboli signals has stimulated much research into embolus 
detection in carotid atherosclerosis.
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4. Carotid atherosclerosis
In 1992 Siebler31 described microembolic signals in two patients with 
internal carotid artery stenosis and one subject with occlusion, and 
compared their findings with 10 normal subjects. Signals were found in 
all three diseased patients with an average rate of embolism of four 
signals per hour. These were detected ipsilateral to the diseased carotid 
artery and exceeded the background arterial waveform by 12-21 dB 
(compared to gas embolism signals which typically exceed the 
background signal by up to 40 dB). This initial short report was then 
expanded as a study of 14 patients before and after carotid 
endarterectomy.34 All the patients were symptomatic and had signals 
detected ipsilateral to the diseased internal carotid artery. Four also had 
contralateral signals. There was a drop in the mean rate of embolism 
(from 11 to 0.4 per hour) following endarterectomy. The authors 
suggested that TCD embolus detection may represent a “new marker of 
disease activity of extracranial carotid artery stenosis”. Additional 
evidence in favour of this was their discovery that symptomatic 
patients with carotid artery stenosis had a higher rate of embolism than
'ic t #
asymptomatic patients. The mean rate of signals in 27 symptomatic 
patients was 14 signals per hour. These subjects all had high grade 
stenosis of the ipsilateral internal carotid artery and a recent (<121
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days) history of ischaemic symptoms attributable to the diseased artery. 
Asymptomatic subjects were found to have a mean rate of 0.35 per 
hour and only 9 of 56 subjects had detectable signals. Another study of 
symptomatic patients found a 94% incidence of microembolism with a 
mean of 14 signals per hour in the ipsilateral artery and 4 per hour in 
the contralateral side. The signals were abolished following 
endarterectomy.
Markus found embolic signals in 3 of 10 symptomatic patients prior to 
carotid angioplasty.90 Only one subject had signals following the 
procedure. In a separate study they found signals in 6 of 25 patients 
with asymptomatic carotid artery stenosis.99
If signals in carotid or cerebral atherosclerosis are caused by platelet or 
leukocyte clumps then treatment with either aspirin or anticoagulants 
would be expected to show an effect on the numbers of signals 
detected. Three case reports have now been published32,100,101 with 
conflicting results. Randomised controlled trials are obviously
♦ 109 ♦ * •required and provisional results in prosthetic valve patients have
1 09shown no effects. Further studies in different clinical settings are 
underway.
The importance of embolic signals in carotid artery stenosis was 
emphasised by the publication of results from the Asymptomatic 
Carotid Atherosclerosis Study (ACAS).104 This large multi-centre
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American study is a randomised trial of carotid endarterectomy for 
asymptomatic high grade stenosis of the internal carotid artery. It is 
discussed in detail later in chapter 10. All patients enrolled for the 
study had computed tomography brain scans performed at baseline and 
126 of 848 patients studied (15%) were found to have cerebral infarcts. 
This incidence of silent cerebral infarction is very similar to the 
incidence of silent cerebral embolism detected by TCD in carotid 
artery stenosis. It suggests that the signals detected may represent 
harmful emboli which result in cerebral injury. In addition embolus 
detection may help to identity which asymptomatic subjects with 
carotid stenosis are most at risk of embolic stroke and therefore benefit 
from surgery. This is particularly important since the perioperative 
morbidity and mortality for carotid endarterectomy is 2-3% even for 
experienced surgeons. The absolute risk reduction offered by 
endarterectomy in asymptomatic individuals is only 5.8%, therefore a 
technique for identifying high risk individuals is needed to increase the 
benefit / risk ratio.
In vitro studies have been performed in sheep to determine signal 
characteristics of differing embolic materials. Markus105 introduced 
thrombi, platelet aggregates and atheroma into the proximal carotid 
artery of a sheep and monitored the cerebral circulation. Emboli as 
small as 5-20 pm were detected successfully. There was a significant
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correlation between the embolus size and the duration and intensity of 
the signal. However it was not possible to determine the embolic 
constituents unless the particle size was known. For example, a small 
fat embolus may produce the same signal as a large solid embolus.106'8 
This has been particularly relevant in determining the nature of emboli 
in subjects with prosthetic heart valves where many hundreds of 
signals may be detected per hour.
5. Cardiac valves
Rams et al109 studied 26 patients with prosthetic aortic valves and 
found a variable incidence and rate of cerebral embolism. Signals were 
detected in 14 subjects (53%) with a mean rate of 38 per hour. The 
maximum rate was 138 per hour in a subject with a Bjork-Shiley valve 
prosthesis. Although the patients were asymptomatic the authors were 
concerned about previously published evidence of long-term functional 
psychometric abnormalities in prosthetic valve patients110 which may 
be related to chronic subclinical cerebral embolism. The signals 
detected were of high amplitude and thus suggestive of gas embolism 
but the cause of the emboli was unclear. Cavitation during valve leaflet 
closure is one possibility but this would be unlikely in bioprosthetic 
valves which have lower valve leaflet closing velocities and less 
resultant turbulence. In addition bubbles produced by cavitation were
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thought to persist for only a few milliseconds111 and thus would not 
persist in the circulation for the time taken to travel from the heart to 
the cerebral circulation.
1 19Grosset et al studied 50 patients with mechanical prostheses and 14 
with porcine bioprosthetic implants. There was a significantly higher 
incidence of microembolic signals in subjects with mechanical 
prostheses compared to porcine valves (88% versus 14%, p<0.01) and 
also a higher rate of embolism in patients who had undergone double
11 T •valve replacement. A further study by the same group found a higher 
rate of embolism in patients with Bjork-Shiley valves compared to 
Medtronic-Hall and Carpentier-Edwards (89% versus 50% and 53% 
respectively, p<0.001). They studied a total of 179 patients, 85 with 
Bjork-Shiley, 56 Medtronic Hall, 38 Carpentier-Edwards valves and 
compared the results to 25 normal subjects. No correlation was found 
between microembolic signals and clinical parameters such as history 
of neurological deficit or intensity of anticoagulation. A study 
comparing coagulation activity and emboli counts in patients with 
prosthetic valves found no correlation between microembolic signals 
and D-dimer, antithrombin III, thrombin-antithrombin III complex or 
intensity of anticoagulation.114 These results suggested that the emboli 
did not cause activation of the coagulation cascade and as such were
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unlikely to result from platelet or leukocyte activation during valve 
closure or caused by turbulent flow through the valve.
Comparing signal characteristics between patients with carotid artery 
disease, atrial fibrillation and prosthetic valves115 it was possible to 
develop an algorithm to help determine the underlying nature of the 
embolus. Using this technique an estimated 92% of signals in 
prosthetic valve patients were gaseous (based on the maximal 
amplitude and the sum of amplitudes of the signals). The signals 
detected during cardiac catheterisation were used to define the 
characteristics of gas emboli and carotid atherosclerosis signals were 
assumed to be due to solid or formed matter emboli.
There is accumulating evidence to support the theory of cavitation as a 
cause for gaseous microembolic signals in prosthetic valve patients and 
a recent study using transoesophageal echocardiography116 appears to 
confirm this. In this study 138 patients with prosthetic cardiac valves 
underwent transoesophageal echocardiography. Microbubbles were 
directly visualised in 69 (35%) of subjects. The bubbles were more 
common in mitral compared to aortic valves and were similar to those 
detected during injection of contrast to detect right-to-left shunting. 
This suggests that cavitation does occur in vivo and that bubbles 
persist in the circulation presumably because of plasma viscosity to be 
detected in the middle cerebral arteries by transcranial Doppler
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ultrasound. There is no convincing evidence to link the microemboli to 
cerebral injury but it is of interest that some valve types cause less 
signals than others, and perhaps function in a more physiological 
manner without the risk of red cell injury and haemolysis. Embolus 
detection may provide an in vivo method of determining the degree of 
turbulence caused by valve types and be used to refine valve design.
6. Shunt detection
The high levels of sensitivity demonstrated by TCD in detecting gas 
emboli are already of clinical relevance. Investigation for right-to-left 
shunting is required in young patients with embolic stroke but without 
an obvious source of embolism in the arterial circulation. Studies 
suggest that an appreciable proportion may have venous thrombosis 
which can embolise through the atrial septum, so-called paradoxical
117 1 7 0embolism. ' A study of 406 patients with clinically suspected 
embolic events found that 264 had unexplained emboli with no overt 
source of embolism (defined as endocarditis, mitral valve stenosis, left 
ventricular mural thrombus or akinesia, spontaneous echocardiographic 
contrast, left atrial or appendage thrombus or myxoma). Of these, 49 
subjects (19%) had right-to-left shunting detected by transoesophageal 
echocardiography. These subjects then underwent venography and 24 
(57%) were found to have venous thrombosis. Up to 30% of healthy
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adults have a potential route from the right to left heart through a
191patent foramen ovale. This may also be relevant to divers where 
paradoxical embolism of venous gas bubbles has been implicated in
199the development of decompression sickness. This is particularly 
relevant to individuals who develop decompression sickness despite 
following recommended decompression procedures.
Until recently the most commonly used technique for the detection of 
shunting was transthoracic echocardiography during the injection of 
intravenous contrast into a peripheral vein. However, performing 
echocardiography during the provocation necessary to increase right 
atrial pressure (coughing and Valsalva manoeuvres) is difficult. The 
most sensitive and specific technique for shunt detection is 
transoesophageal echocardiography, but this is an invasive technique 
which is unsuitable for screening healthy individuals, such as divers. 
TCD during peripheral contrast injection was compared directly with 
transthoracic echocardiography in a study of 46 patients. Shunting 
was detected in 41% of subjects by TCD, but only 26% by 
echocardiography. A further study124 compared TCD with 
transoesophageal and transthoracic echocardiography. 
Transoesophageal echocardiography detected shunting in 19 of 49 
subjects, TCD detected paradoxical signals in 13 of these subjects 
whereas the transthoracic technique only detected 9 subjects. TCD had
39
68% sensitivity and 100% specificity relative to transoesophageal 
echocardiography, and was superior to transthoracic echocardiography 
(only 47% and 100% respectively). A further direct comparison was
19Smade between TCD and transoesophageal echocardiography and 
TCD was found to have 93% sensitivity, detecting 14 of 15 patients 
with PFO.
It is possible to increase the detection of shunting by increasing right 
atrial pressure, usually by coughing or performing a Valsalva
1 76manoeuvre. This is possible during TCD without losing the 
ultrasound signal, unlike transthoracic echocardiography.
7. Summary
TCD ultrasound is a reliable and convenient method of monitoring the
197 I 98arterial circulation for circulating emboli. ’ The clinical relevance 
of gas emboli is uncertain in prosthetic valve patients but evidence 
suggests that solid emboli are more likely to cause cerebral injury. It is 
possible to estimate the constituents of an embolus if assumptions are 
made regarding the particle size. Artificial gas emboli can be 
introduced into the venous system and used as a non-invasive 
technique for detecting right-to-left shunts.
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CHAPTER 4 METHODS
Ultrasound techniques
All of the techniques described below require high frequency energy to 
be emitted, reflected from body tissues or moving material and then 
detected, analysed and displayed. The basic mechanism is the same in 
all types of ultrasound imaging which simply involves the use of 
reflected ultrasonic energy waves. The most commonly used 
frequencies in clinical medicine are between 2 and 10 MHz (audible 
sound extends to 20kHz, or 20,000 cycles per second). The higher 
frequencies allow greater resolution of detail when imaging but at the 
cost of poor penetration such that, for example, frequencies greater 
than 5 MHz are rarely useful in adult echocardiography because of poor 
penetration through the chest wall. However, more superficial 
structures such as the carotid or brachial arteries can be studied with 
frequencies exceeding 10MHz and thus with much higher resolution.
Various methods of ultrasound analysis are available:
A-mode refers to amplitude and provides radiofrequency displays 
which are used in wall tracking devices to measure small changes in 
arterial diameter during the cardiac cycle. The display does not provide 
any structural information other than distance within a single line of
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ultrasonic energy. Strong reflectance signals are presented as high 
amplitude peaks.
B-mode refers to Brightness and is used in clinical practice to provide 
anatomical images, for example of the carotid artery. A B-mode image 
is normally constructed from multiple lines of ultrasound energy to 
provide a 2 dimensional image. Strong reflectance signals are shown as 
bright dots or pixels. High resolution B-mode uses high frequency 
ultrasound (typically 8-10MHz) and can be used to measure distances 
approaching 0.01mm.
M-mode displays Motion analysis of a single B-mode scanning line. 
By imaging one line of analysis continuously and scrolling the display 
horizontally it is possible to analyse movement of structures against 
time. This is used during echocardiography, for example to measure 
left ventricular dimensions during systole and diastole. The ECG is 
usually superimposed on the M-mode image to allow accurate timing.
Doppler ultrasound is used to measure the speed of blood flow based 
on the shift in frequency between transmitted and reflected energy 
waves. Colour flow Doppler allows colour mapping of flow jets and is 
used in clinical practice, for example in valvular heart disease or 
carotid artery stenosis.
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Echocardiography
Echocardiography was performed in these studies to measure left 
ventricular structure and function. It was also used to exclude patients 
with significant cardiac structural abnormalities such as valvular 
disease. Left ventricular structural assessment involved measuring wall 
thickness and internal dimensions during systole and diastole. From 
this it was possible to estimate left ventricular mass. Diastolic function 
was also assessed by measuring the speed of blood flowing through the 
tips of the mitral valve leaflets using pulsed wave Doppler as described 
below.
The examinations were performed in a standardised manner with the 
subject lying in the left lateral position. An Acuson 128 (Acuson, 
Mountain View, California) with a 3.5MHz probe was used. Three 
representative M-mode images from the left parasternal view of the left 
ventricle were displayed as full screen images and recorded on 
videotape. Each image allowed measurement of dimensions during up 
to 5 cardiac cycles depending on heart rate. Subsequent analysis was 
performed off-line on five cardiac cycles to allow estimation of 
interventricular septal thickness in systole and diastole (IVSs, IVSd), 
left ventricular end systolic and diastolic diameters (LVESD, LVEDD) 
and left ventricular posterior wall thickness (LVPWs, LVPWd). 
Measurements were performed according to the recommendations of
1 9Q
the American Society of Echocardiography.
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Figure 4. Example of M-mode echocardiography.
I C flL =18M
AMVL
PMVL
M-mode image of left ventricle (LV) at the level of the mitral valve 
leaflets (AMVL= anterior, PMVL posterior mitral valve leaflets). IVS 
(interventricular septum) and PW (posterior wall) move together in 
systole. M-mode cursor placed according to the miniature 2-D image 
seen at the top of the screen.
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Figure 5. Example of 2-D parasternal echocardiography.
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2-D parasternal long axis view showing left atrium (LA), left ventricle 
(LV), interventricular septum (IVS), posterior wall (PW) and aortic 
root at the level of the valve cusps (AO).
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Diastolic function was assessed using pulsed wave Doppler with the 
sample volume positioned between the tips of the mitral valve leaflets. 
The E:A ratio was calculated as the ratio of the peak E or early phase 
of left ventricular filling to the A velocity which represents active 
atrial contraction. The isovolumetric relaxation time (IVRT) was 
defined as the interval between the aortic valve closing and the start of 
the E wave and was measured using continuous wave sampling across 
the aortic root and mitral valve.9 The E:A ratio and IVRT reflect left 
ventricular compliance during diastolic filling. All diastolic 
measurements were performed off-line using the ACUSON analysis 
software on five cardiac cycles recorded during end expiration. Each 
video recording was a full screen image frozen prior to recording to 
allow accurate calibration. All video recordings were on broadcast 
quality super VHS video tape.
High resolution B-mode carotid ultrasound
High resolution B-mode ultrasound was used to examine the common 
carotid artery and to measure intima-medial thickness (IMT) as well as 
detection of atherosclerotic plaque. The technique has been reviewed
i 'inin detail elsewhere and has been well validated against post mortem 
and surgical specimens.
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Figure 6. Example of high resolution B-mode ultrasound scan
This image has been digitised from a video recording of a high resolution B- 
mode carotid ultrasound scan. The scan is identified by a randomised 
examination number (top left). The calibration marker is placed on screen by the 
Biosound device and allows accurate calibration for measurement of intima- 
medial thickness. The size of the calibration marker is displayed in the top right 
comer.
This scan is of the right common carotid artery with the skin on the left of the 
image and layers of subcutaneous fat and the jugular vein between the surface 
and the carotid artery.
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The first published use of high resolution B-mode ultrasound was by
1^1Pignoli et al in 1986 who demonstrated the two parallel lines 
resulting from the intima-medial layer and found that it was not 
possible to discriminate between the intimal and medial layers. Axial 
resolution was found to be 400pm and subsequent work with the B- 
mode technique has shown variable axial resolution between 200 to 
600 pm depending on the frequency of ultrasound. The Biosound 2000 
II SA (Bio Dynamics inc., Indianapolis) used in this thesis has a 
maximum resolution of 385pm when used with a 8 MHz probe. The 
image is composed of 256 levels of grey (30 are distinguishable by 
eye) and stored on super VHS tape which gives 450,000 pixel images.
The ultrasound examination was performed according to the protocol 
for the ELSA study (European Lacidipine Study on Atherosclerosis, 
Glaxo S.p.A. and Boehringer Ingelheim) which is a large multicentre 
study of carotid IMT progression in hypertension and which involves 
serial measurements of IMT in patients randomised to either an 
atenolol or a lacidipine based antihypertensive drug regimen. The 
Biosound 2000 was chosen as the instrument to perform high 
resolution B-mode scans because it has been well validated in 
previous large scale epidemiological studies including the
|  OQ
Atherosclerosis Risk in Communities study, ARIC. ’
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The examination was performed with the subject lying in a supine 
position which allowed head rotation to either side. Instrument settings 
on the Biosound 2000 II SA were standardised at the beginning of the 
examination. The examination started on the right side by placing the 
transducer on the skin longitudinal to the common carotid artery. The 
image of the relevant arterial segment was placed in the middle third 
of the screen to minimise axial distortion. The transducer then was 
moved slowly cranially keeping the common carotid artery in focus 
until the start of the carotid bulb immediately proximal to the 
bifurcation. The probe then was gradually rotated first anteriorly then 
posteriorly to allow measurement of the maximum IMT in this arterial 
segment thus accounting for both concentric and eccentric thickening.
A similar procedure was adopted for the left side but the transducer 
design causes the image to be inverted with the cranial end of the 
artery at the bottom of the screen. A bilateral examination took 
between 25 and 30 minutes. Sonographers were specially trained to 
perform research quality B-mode scans with a tightly controlled 
examination protocol. Regular quality control and annual 
recertification ensured continuing high standards. Examinations were 
recorded on super VHS video tape and identified on screen by a 
random number without identifiable patient details allowing 
subsequent analysis independent from any clinical data.
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Measurement o f  IM T
The measurements of carotid artery IMT are from my own blinded 
analysis of the ultrasound recordings rather than central analysis by the 
ELSA measurement centre in the Bowman Gray School of Medicine 
(Winston-Salem, North Carolina). The problem of calibration was 
overcome by using the Biosound to display a marker of known length 
on screen throughout the ultrasound examination. This line varied in 
length and position throughout the recording period. A problem with 
studies involving video tape analysis of arterial disease is that 
calibration is usually based on an intra-arterial catheter of known 
diameter. This causes difficulty since the video image is a two 
dimensional representation of a three dimensional structure which 
causes distortion of both catheter and arterial size. B-mode ultrasound 
provides images of a two dimensional slice of tissue, a significant 
advantage.
Analysis of video tapes was then performed blinded to the clinical 
data. The tape was played through a frame stabilising device interfaced 
with an image digitiser and a 486DX microprocessor based computer 
(Digital time base corrector FA-310 P, FOR-A Company Ltd, Tokyo). 
The image was frozen when a suitable view of the common carotid 
artery immediately proximal to the bifurcation was available.
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The image was magnified by a factor of eight before measuring the 
length of the calibration marker and calculating IMT using the 
quantitative computerised analysis system (Cardiotrace version 3.03, 
Cinegraphic Inc, Grand Prairie, Texas). The final IMT value was 
based on the mean of three separate measurements. When a discrete 
arterial plaque was present, IMT was measured in the segment 
immediately proximal to that plaque. Plaque thickness was also 
measured where present and the echogenic characteristics of the lesion 
were noted including the presence of calcification, ulceration and 
intraplaque haemorrhage. Plaque was defined as a focal area of intima- 
medial thickening exceeding that of the adjacent segment by over 30% 
and being at least 1.3mm in thickness as defined in the ELSA study 
protocol (Glaxo S.p.A., Italy and Boehringer Ingelheim, GmbH, 
Germany).
The IMT values were entered into a database file containing the 
random identification number only. This was unblinded automatically 
by computer by a specially written computer program which combined 
separate database files independently of operator control. Subjects had 
individual clinical information database files and separate files with 
tape identification numbers to record the IMT values. Thus all 
measurement was completely independent of clinical data.
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Carotid Doppler ultrasound and arterial pulsatility
Carotid Doppler ultrasound is used clinically to measure blood flow 
velocity and to estimate lumen stenosis based on an increase in 
velocity. It involves duplex ultrasound which combines B-mode 
images of the arterial segment and pulse wave Doppler sampling of 
blood flow velocity within a small sample volume which can be 
moved to each of the carotid artery branches.
Carotid Doppler ultrasound was performed using an Acuson 128 with 
a 7.5 MHz probe. The subject lay supine and the probe was placed 
over the common carotid artery above the clavicle and moved 
gradually towards the bifurcation and origin of the internal and 
external carotid arteries. Duplex scanning was used to obtain B-mode 
images of the carotid arteries before colour flow mapping to confirm 
the high blood flow velocities of arterial rather than venous blood 
flow. A cursor was then placed in the centre of the common, internal 
and external carotid arteries and three separate measurements of 
systolic and diastolic velocity were made, each consisting of the 
average of five cardiac cycles. When measuring blood flow velocity, 
the sampling volume was angled along the line of blood flow but kept 
to less than 30° from the cursor to minimise distortion which can 
exaggerate blood flow velocity.
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Representative waveforms were stored on super VHS videotape and 
identified by number without patient details. Post examination 
analysis was possible since the Acuson recorded electronic calibration 
information which allowed estimation of blood flow velocities using 
the Acuson analysis software. This was performed in a blinded manner 
and unblinded by computer as above.
A-mode arterial compliance measurement
Carotid arterial compliance was measured using a wall tracking device 
(AMA, Holland) linked to the Acuson 128. The device allows accurate 
and reproducible measurement of dynamic changes in arterial diameter 
during the cardiac cycle. A 7.5 MHz probe was used to provide a B- 
mode image of the carotid bifurcation. The common carotid 
bifurcation was identified and the segment 2cm proximal to the bulb 
was aligned in the centre of the screen. An M-mode cursor was then 
placed through the centre of the section and the subsequent M-mode 
output was enlarged to occupy the entire screen. Using a foot switch 
the wall tracker was triggered to analyse five cardiac cycles of carotid 
dimensions. The wall tracker provided an audible tone once this 
information had been stored and the ultrasound probe was removed 
from the subject’s neck. This procedure was repeated 3 times.
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The radiofrequency profiles (A-mode output) were analysed and 
sample volume cursors placed around the anterior and posterior wall 
signals as identified by the distance measured from the M-mode 
image. The computer was then used to analyse movement within the 
sample volumes and calculate a high resolution graph of arterial 
dimensions throughout five cardiac cycles. Three measurement 
recordings were stored (five cardiac cycles each) if they were of 
adequate quality. The recordings were stored on computer hard disc 
and identified by a numerical examination number.
All measurements were performed off-line on five cardiac cycles to 
allow mean distensibility, minimum diameter (end diastole) and rise 
time to be calculated. The rise time is the time taken to move from 
10% to 90% on the distensibility curve. In addition Duplex ultrasound 
was used to exclude haemodynamically significant atherosclerosis (not 
present in any subject in the compliance study). Measurement results 
were entered into a database file containing subject identification 
numbers only. These were then transferred automatically to the 
clinical database files to avoid observer unblinding.
Transcranial Doppler ultrasound embolus detection
TCD monitoring was performed using a Nicolet TC4040 or TC2000 
(Nicolet, Warwick, UK) with a 2 MHz probe. This low frequency
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enables detection of reflected ultrasound energy waves through bone. 
The probe was held in position over the temporal window using an 
elasticated head piece. In the case of the TC4040, bilateral monitoring 
was performed simultaneously. Patients rested supine with the head 
supported on two pillows and were asked to remain as still as possible. 
Talking was discouraged to eliminate any artefact caused by jaw 
movement, although such artefact is easy to distinguish from embolic 
signals as described below.
The middle cerebral arteries were monitored for 30 minutes on each 
side focusing on the signal at 48-52 mm from the skin. All recordings 
were stored on videotape for independent analysis by two observers. In 
addition digital data from the fast Fourier transformation of the 
Doppler waveform data were stored on computer hard disc for 
subsequent analysis. In the study described in Chapter 10 (carotid 
atherosclerosis) embolus counting was performed prior to the carotid 
Doppler ultrasound to reduce any potential bias. Microembolic signals 
were defined as characteristic high intensity transient signals which 
were easily distinguished from the background arterial waveform. 
They had to be unidirectional, unlike artefact which typically produces 
bi-directional signals, and associated with an audible chirp or blip.
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Shunt detection
Divers were screened for right-to-left shunting by simultaneous 
transthoracic echocardiography and transcranial Doppler ultrasound 
during injection of contrast. An 18 gauge indwelling cannula was 
inserted into a left brachial fossa vein. Microcavitation contrast was 
generated by agitating 5mls of 0.9% saline, 0.2mls air and 0.5mls of 
the subject’s blood between two 10ml syringes using the three way tap 
method.124 The mixture contained microscopic air bubbles which 
cause very intense reflection of ultrasound energy and which can be 
detected in the heart or in the peripheral arteries if there is a 
connection between the venous and arterial systems. The mixture was 
injected with the subject supine and breathing quietly. The injection 
was repeated following the sudden release of a Valsalva manoeuvre, 
and if necessary after coughing. Each stage was repeated twice if 
embolic signals were not detected. These techniques have been shown 
to maximise the chance of detecting right-to-left shunting124’6 by 
increasing right atrial pressure and provoking shunting.
A positive test was defined during echocardiography as the appearance 
of bubbles in the left heart within five cardiac cycles of the right heart 
opacifying. Shunting during transcranial ultrasound was defined as 
the appearance of characteristic audible blips and the presence of 
embolic signals superimposed on the middle cerebral artery Doppler
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waveform within the same period. The signals detected were of high 
amplitude, short duration and were irregular in relation to the cardiac 
cycle. In addition signals had to be detected bilaterally to confirm a 
cardiac source of embolism.
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CHAPTER 5 ECHOCARDIOGRAPHY
Cardiac abnormalities in white coat hypertension 
Background
Echocardiography is widely used in clinical practice to assess cardiac 
function and structure. It includes techniques which allow estimation 
of left ventricular mass as well as measurement of ventricular filling 
velocities. This is relevant to hypertension where early abnormalities of
7 i '\ 'y  iventricular filling ■ " can be found before the more serious
development of muscle hypertrophy which is a prognostic marker for 
cardiovascular morbidity and mortality.6,138 It is clinically important to 
identify individuals at risk of developing left ventricular hypertrophy 
and to direct antihypertensive treatment accordingly.
Left ventricular hypertrophy
Much of the data concerning left ventricular hypertrophy comes from 
the cohort follow-up studies performed in Framingham, Massachusetts. 
This long-term population based follow-up study first started in 1948 
and involved repeated medical assessments in addition to 
echocardiography. Measurements of left ventricular dimensions were 
made with M-mode echocardiography and were used to estimate left 
ventricular mass. Devereux et al developed a formula to estimate left
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ventricular mass from ultrasound measurement of ventricular diameter 
and wall thickness following post-mortem comparisons with cardiac 
weight.5,139 This approach has been validated in other centres3,4 and 
echocardiographic estimation of left ventricular mass is now widely 
accepted.
One of the Framingham follow-up studies6 involved monitoring 3220 
subjects over four years in terms of cardiovascular mortality following 
estimation of left ventricular mass by echocardiography. During the 
study period 208 cardiovascular events were recorded. Left ventricular 
mass was found to be an independent predictor of cardiovascular 
events even after correction for confounding factors including age, 
diastolic blood pressure, pulse pressure, treatment for hypertension, 
cigarette smoking, diabetes, obesity and cholesterol. There was a 
continuous relationship between left ventricular mass and 
cardiovascular risk such that increments in left ventricular mass were 
associated with correspondingly higher rates of cardiovascular events. 
The relative risk of all cause mortality if left ventricular hypertrophy 
was present was 1.49 (95% Cl 1.14 to 1.94) for men, and 2.01 (95% Cl 
1.44 to 2.81) for women, compared to subjects without ventricular 
hypertrophy. Left ventricular mass was corrected for subject height in 
this study whereas more recent studies use body weight to derive the 
left ventricular mass index.
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The Framingham study authors hypothesised that left ventricular 
hypertrophy demands an increase in myocardial oxygen requirement 
while reducing the coronary blood flow reserve and this imbalance may 
be responsible for the increased risk of angina, myocardial infarction 
and sudden death.
Further research from the Framingham studies confirmed the 
prognostic value of estimating left ventricular mass in elderly subjects 
with hypertension.140 A separate smaller study of 140 men confirmed 
that echocardiographic measurement of left ventricular mass had 
greater prognostic value than electrocardiographic grading of left
• Qventricular hypertrophy. They also identified abnormalities of left 
ventricular filling using Doppler ultrasound in hypertensive subjects. 
This has stimulated further research into ventricular diastolic function 
which is discussed below.
Left ventricular diastolic function
Left ventricular filling normally consists of an early passive phase 
when the ventricle actively relaxes and draws blood from the atrium by 
suction.141 This active phase is energy dependent and results from 
myocardial cell lengthening as calcium ions are removed from the 
cytoplasm and contractile proteins by an adenosine triphosphate 
dependent enzyme in the sarcoplasmic reticulum. Removing calcium
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causes the actin and myosin bonds to dissociate and causes muscle 
fibres to lengthen. The later stage of ventricular filling is determined by 
the mechanical properties of the ventricle in terms of elasticity and 
compliance. As the ventricle becomes stiffer more active atrial 
contraction is required to overcome the reduction in ventricular 
compliance.
Using pulsed wave Doppler it is possible to identify two discrete 
phases of ventricular filling. The early (E) phase is the active relaxation 
phase where the ventricle fills by suction and the second is caused by 
active (A) atrial contraction. If ventricular compliance is reduced there 
is a fall in the E:A ratio and this provides an objective measure of 
ventricular elasticity. In addition, changes in the E deceleration and A 
deceleration time are also observed (see table 5.1).
The isovolumetric relaxation time (IVRT) is the interval between the 
aortic valve closing and the mitral valve opening. This indicates the 
time required for ventricular pressure to fall below atrial pressure and 
this is prolonged in hypertension.
There has been considerable research examining left ventricular 
diastolic function in hypertension and this has been shown to be 
influenced by age, sex, body weight, height, family history of 
hypertension, antihypertensive treatment, presence of left ventricular 
hypertrophy and coronary artery disease.7,9,73,132'3,135’137,142'147
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Diastolic parameter Normal range Effect of 
hypertension
E velocity 0.85 ±0.16 m/sec 4
A velocity 0.56 ±0.13 m/sec T
E deceleration time 199 ± 32 msec t
Isovolumetric 69 ± 12 msec (<40 years) T
relaxation time
76 ± 13 msec (>40 years)
Table 5.1 Effect o f  hypertension on diastolic function9
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Changes in diastolic function have been described in the offspring of 
hypertensive parents73 which may develop prior to left ventricular 
hypertrophy. However, diastolic dysfunction may also be associated 
with the future development of systolic dysfunction and the clinical 
consequences of left ventricular failure.149
Antihypertensive treatment can result in favourable changes in 
diastolic function as well as reducing the incidence and slowing the 
progression of left ventricular hypertrophy.146,150 Calcium channel 
antagonists have been shown to improve diastolic function in 
hypertension and myocardial disease.151 However, no study yet has 
shown significant benefit in terms of mortality after improvement of 
diastolic dysfunction. This is discussed in detail in a recent review146 
and is summarised below. Diuretics decrease venous return and 
therefore reduce left ventricular filling volume in a similar manner as 
nitrates. Beta blockers have also been shown to be effective 
(metoprolol and nadolol) but only if blood pressure is reduced. They 
act by prolonging the period available for ventricular filling during 
diastole, partly by reducing the resting heart rate. This counterbalances 
their adverse effect on ventricular relaxation which is slowed.
White coat hypertension
The benefits of treating established hypertension are well recognised
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with significant reductions in cerebrovascular, cardiac and even
vascular disease.152 There may also be additional benefits in that drug
treatment may interfere with the development and progression of
atherosclerotic vascular disease with potential long-term reductions in
cardiovascular morbidity.15,186 However, the major trials of
antihypertensive treatment relied upon conventional clinic
measurement of blood pressure to identify hypertensive patients and
this has led to the inclusion of individuals with white coat
hypertension. Blood pressure measurements are usually higher when
first attending a doctor and even after repeated visits this startle
reaction can persist. Using ambulatory blood pressure monitoring it has
been shown that 20-40%9,154-7 of individuals classified as persistent or
borderline hypertensives by conventional clinical measurement can be
reclassified as normotensive during daytime monitoring. Unfortunately
the criteria for defining white coat hypertension varied in these studies
and there is not yet a universally agreed definition. For example, one 
1group used an elevated clinic diastolic pressure (between 90- 
104mmHg) but with normal daytime ambulatory blood pressures
fL
(below the 90 percentile of a normotensive control group). Another 
study defined the syndrome as a mean office blood pressure at least 6 
mmHg higher than the ambulatory mean blood pressure.154
While the influence of medical personnel on blood pressure
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measurement has also been well studied,159 leading to 
recommendations for repeated clinic measurements before initiating 
treatment,160 it now is established that even those clinical studies which 
included white coat hypertensives showed reductions in cardiovascular 
disease. In general it has been assumed that the inclusion of such 
patients diluted the magnitude of benefit but an alternative possibility 
is that the white coat hypertensives may also have benefited from 
treatment. There is no definitive answer to this question from end-point 
studies. However, since the effects of hypertension on the 
cardiovascular system also manifest as functional abnormalities, or
|  -JQ
surrogate end-points, including abnormalities of arterial compliance 
and of diastolic left ventricular function, there is the additional 
possibility that these may also be reversible with treatment.151
The principal aim of our study was to determine whether or not white 
coat hypertensives differ from persistent hypertensives or 
normotensives in terms of known markers of hypertensive 
cardiovascular disease. Thus a range of indices of cardiovascular 
function were assessed in patients referred for evaluation of their 
hypertension.
Methods
65 patients referred for assessment of hypertension were invited to give
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written informed consent to this study which had prior approval from 
the local Ethics Committee. Eligible patients were aged 45-75 years 
and had no evidence of clinically significant disease, including 
previous myocardial infarction, stroke, cardiac failure, insulin 
dependent diabetes, renal impairment, liver disease, atrial fibrillation or 
significant heart valve disease. They were not taking antihypertensive 
treatment, or any other treatment liable to alter arterial compliance or 
left ventricular function at the time of the study, and had not received 
any such treatment within 28 days of the study. Patients had attended 
for blood pressure measurements on at least two previous occasions.
Blood pressure measurements
Clinic blood pressure was measured using a semi-automatic 
oscillometric device (Sentron, Bard Inc, UK) which was programmed 
to record blood pressure automatically without a member of staff 
present. This was performed to diminish any elevation of blood 
pressure related to the presence of medical staff. Measurements were 
taken in a standard setting after the patient had rested supine for a 
minimum of 15 minutes following a 10 hour fast. Three measurements 
were taken with intervals of 5 minutes, and the mean was calculated.
Ambulatory blood pressure monitoring was performed over a 28 hour 
period using SpaceLabs 90207 monitors (SpaceLabs, Inc. Redmond,
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WA) which were programmed to record blood pressure every 15 
minutes during daytime, and every 20 minutes overnight.
A minimum of 3 readings per hour during daytime and 2 readings per 
hour overnight were required for a record to be deemed satisfactory.
Cardiac indices
Echocardiography was performed using an Acuson 128 as described in 
chapter 4. All echocardiographic measurements were analysed by one 
observer. The coefficient of variation for E:A ratio measurement in a 
random sample of 20 subjects from the study population was 2.8%.
Classification o f  patients
According to the study protocol, three groups of patients were defined 
on the basis of ambulatory blood pressure monitoring profiles and 
clinic recordings: persistent hypertensives who had a diastolic pressure 
> 95 mmHg both at the clinic and on daytime ambulatory monitoring; 
white-coat hypertensives who had a diastolic pressure of 95 mmHg (or 
more) at the clinic but not on ambulatory monitoring; and 
normotensives who had diastolic pressures below 95 mmHg at all 
times. These arbitrary definitions were based on the thresholds for 
initiating treatment recommended by the World Health Organisation 
and the International Society of Hypertension,160 and the criteria
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1defined in a large study of white coat hypertension.
All ultrasound analysis was done independently of the blood pressure 
recordings. The E:A ratio and IVRT were corrected for clinic blood 
pressure by division using the appropriate blood pressure variable, 
recorded at the time of the ultrasound measurement, and normalising 
for an arbitrary pressure of 120/80 mmHg. Dimensions of the left 
ventricle were measured according to the recommendations of the
190American Society of Echocardiography. Relative wall thickness (a 
measure of the degree of concentric hypertrophy) was calculated as the 
sum of the septal wall thickness and posterior wall thickness at end 
diastole divided by the left ventricular internal dimension. 
Measurements of the left ventricle were calculated by standard 
methods described below:
Left ventricular mass (LVM) was calculated as:
LVM= 1.04 [(LVEDD + LVPWd + IVSd)3 - LVEDD3] -13.6 g
where LVEDD is left ventricular end diastolic diameter, LVPWd is 
posterior wall thickness and IVSd is intraventricular septum thickness. 
This was divided by the body surface area to give the left ventricular 
mass index.139
Left ventricular fractional shortening was defined as:
Fractional shortening= [LVEDD - LVESD] / LVEDD
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where LVESD is left ventricular end systolic diameter.
Statistical analysis
Statistical interpretation of the results was by analysis of variance with 
Fisher’s pairwise comparisons for between-group differences. A chi 
squared (% ) test was used to compare the sex distribution of the 
groups. A p value of 0.05 was considered significant.
Results 
Demographic summary
The characteristics of the 65 study patients are presented in table 5.2. 
There were no significant differences in sex distribution, age, weight or 
height between groups. By definition, clinic blood pressures were 
higher in persistent and white coat hypertensives compared to 
normotensives and ambulatory pressures were higher in persistent 
hypertensives compared to both white coat and normotensives (figure 
7). There were no significant differences in heart rate or pulse pressure 
between groups. Serum creatinine, cholesterol and triglyceride levels 
tended to be higher in the persistent hypertensives but the differences 
did not reach statistical significance (table 5.2).
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Persistent White coat Normal P
Male / female 11/ 9 14/ 8 8 / 15 NS(x2)
Age (years) 55 ± 6 58 ± 8 61 ± 9 NS
Weight (kg) 80.1 ± 18.3 78.9 ± 16.8 70.0 ± 12.4 NS
Height (cm) 166 ± 6 168 ± 11 168 ± 11 NS
Body surface area m2 1.86 ±0.22 1.89 ±0.23 1.88 ±0.21 NS
Heart rate / minute 68 ± 8 63 ± 8 64 ± 10 NS
Creatinine (jimols/1) 87 ± 16 75 ±30 78 ±26 NS
Cholesterol (mmol/1) 6.29 ± 0.88 5.39 ± 1.98 5.79 ± 1.07 NS
Triglycerides (mmol/1) 2.08 ± 0.95 1.43 ±0.97 1.47 ± 1.17 NS
Glucose (mmol/1) 5.5 ± 1.8 4.8 ± 1.8 5.3 ± 0.5 NS
Table 5.2 Patient characteristics (mean ± standard deviation) 
NS, not significant
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Cardiac indices
Analysis of the whole study population confirmed no significant sex 
differences in echocardiographic measurements.
Left ventricular function: these measurements are presented in figures 
8 and 9. The E:A ratio was reduced in both persistent and white coat 
hypertensives (0.94 ± 0.23 and 1.06 ± 0.21 compared to 1.24 ± 0.31 
respectively, p<0.005 ANOVA). This remained statistically significant 
after correction for systolic and diastolic pressures at the time of the 
ultrasound measurement. The isovolumetric relaxation time (IVRT) 
was prolonged in both persistent and white coat hypertensives 
compared to normal (85.7 ± 14.1 ms and 88.8 ± 19.0 ms compared to 
70.8 ± 14.7 ms, p<0.001 ANOVA) but this was not significant after 
correcting for blood pressure.
Left ventricular mass: LV mass, LV mass index and relative wall 
thickness were significantly higher in the persistent hypertensives but 
not in the white coat hypertensives or normotensives; for example LV
• 7 9mass index was 118 ± 36 g/m compared to 86±15 g/m and 99±19
<y
g/m (p<0.01) respectively. Fractional shortening was similar in all 
groups.
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Persistent White coat Normal P
LV mass (g) 209 ± 47* 163 ±32 169 ±53 <0.01
LV mass index 118 ±36* 86 ± 15 99 ± 19 <0.01
(g/m2)
Relative wall 46 ±5* 39 ± 5 43 ± 5 <0.005
thickness (%)
Fractional 22 ± 5 23 ± 12 23 ± 11 0.970
shortening (%)
Table 5.3 Left ventricular systolic function and mass (mean ± SD) 
* significant difference compared to normotensives.
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DISCUSSION
Persistent and white coat hypertensives had similar abnormalities of 
left ventricular diastolic function. These changes are consistent with 
the known effects of hypertension and are caused by impaired diastolic 
filling with a relative increase in atrial activity to complete the filling 
process. Overall there was a reduction in ventricular compliance 
which has been described previously in hypertension. However, the 
abnormalities were also present in the white coat hypertensives and 
the two groups had a similar degree of dysfunction.
These results correspond with the findings of a study in elderly 
hypertensives which reported similar disturbances of diastolic function 
in 17 subjects (mean age 74 yrs) with white coat hypertension.161 
These early changes may precede systolic dysfunction and the 
development of cardiac failure.149 However, we found no significant 
increase in left ventricular mass or mass index in the white coat 
hypertensives compared to normal but our patients were younger on 
average by 15 years and this may simply reflect an earlier stage of 
disease. In contrast the persistent hypertensives in our study, 
presumably at a later stage in the disease process, had increased left 
ventricular mass and mass index, as well as increased relative wall 
thickness consistent with ventricular hypertrophy.
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While the particular level of diastolic blood pressure will certainly 
influence the categorisation of the patient groups, 95 mmHg was based 
on the thresholds for initiation of treatment recommended by the 
World Health Organisation and the International Society of 
Hypertension. This was intended to allow the results to be interpreted 
clinically in the context of initiating antihypertensive treatment in a 
patient found to be hypertensive in the clinic but not according to the 
daytime ambulatory blood pressure average. The threshold chosen led 
to the inclusion, in the white coat hypertensive group, of individuals 
who might be classified as persistent hypertensives according to 
alternative criteria. However, this also led to the inclusion in the 
normotensive group of patients who otherwise might be classified as 
hypertensive. Irrespective of the definition, there is a close 
comparability between the daytime and night time values in the white 
coat and normotensive groups, and these are significantly different 
from the corresponding values in the persistent hypertensives.
Other than by statistical means it is difficult to control for differences 
in blood pressure at the time of measurement in the white coat 
hypertensives since pharmacological manipulation of blood pressure 
would itself change arterial compliance and diastolic function. 
Therefore all diastolic measurements were adjusted relative to an 
arbitrary blood pressure of 120/80 and, after correction, it could be
77
seen that prolongation of the IVRT was attributable to hypertension 
during measurement. However, even after this correction for blood 
pressure, highly significant differences in the E:A ratio remained. 
These differences would persist if any other arbitrary blood pressure 
was chosen, since the statistical correction involves dividing by the 
subjects individual blood pressure at the time of ultrasound and then 
multiplying by a numerical constant, in this case either 120 or 80. The 
discriminating feature is the blood pressure, not the constant. There 
are limitations in the standardisation procedures for the functional 
cardiovascular measurements but in the absence of a previously 
accepted procedure, the measurements were standardised by allowing 
for the slope of the relation between blood pressure and the dependent 
variable (eg E:A ratio or IVRT).
There is recent evidence that white coat hypertension is associated 
with the development of cardiovascular disease with increased rates of 
target organ damage and functional abnormalities such as 
microalbuminuria.162,163 Thus white coat hypertension probably 
represents an intermediate or latent group for morbidity and mortality 
and may have corresponding benefits from antihypertensive treatment.
The clinic blood pressure should be used as a guide to the requirement 
for antihypertensive therapy since it was this measurement that was 
used to include patients in the mortality studies of antihypertensive
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treatment. However, ambulatory blood pressure monitoring is
becoming more widely available and is frequently used to avoid
starting or increasing medication. Until prognostic studies have been
performed there is no clear evidence to support this approach.
Previous small studies have shown low cardiovascular morbidity in
subjects with white coat hypertension24 followed for up to 7.5 years
but 29% of these received drug treatment. Other studies have shown
that persistent hypertension develops in the majority of white coat
hypertensives (75%) and that this progression could not be predicted
1by clinic blood pressure. Therefore it is important to avoid 
classifying white coat hypertensives as normotensive and the 
possibility of transition to persistent hypertension should be 
considered.
The results of this study suggest that white coat hypertension is 
associated with abnormalities of cardiac function. These abnormalities 
have been shown in previous studies of persistent hypertension to be 
reversible with treatment and this suggests that white coat 
hypertensives also may benefit from antihypertensive treatment.
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CHAPTER 6 VASCULAR COMPLIANCE
Carotid arterial compliance in hypertension 
Background
This section describes the use of a Doppler ultrasound wall tracking 
device to study the persistent, white coat and normotensive patients 
detailed in chapter 5. The abnormalities of carotid arterial compliance 
in hypertensives have been reviewed earlier but to date there have been 
no studies of white coat hypertensives using wall tracking technology. 
In addition, left ventricular diastolic function has yet to be related to 
vascular compliance measurements even though they essentially 
measure complementary aspects of the arterial circulation. These 
techniques have been described earlier. The principal aim of this sub­
study was to investigate functional aspects of the large arteries in 
relation to the functional abnormalities in the left ventricle.
Methods
The inclusion and exclusion criteria are described in chapter 5. This 
study used the same population with blood pressure profiles as defined 
previously.
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Carotid arterial compliance was measured using a wall tracking device 
connected to the Acuson 128 as described in chapter 4.
Wall tracking analysis
All ultrasound measurements and calculations were performed 
independently of any blood pressure data. The pressure-strain elastic 
modulus (Peterson’s modulus; Ep) and stiffness index were calculated 
as defined earlier in chapter 2.
The distensibility coefficient (DC) was calculated as:
DC = [2 x distension] / [minimum diameter x pulse pressure ]
Statistical analysis
Statistical interpretation was by analysis of variance with Fisher’s 
pairwise comparisons for between group differences. A p value of 0.05 
was considered significant.
RESULTS
The clinical characteristics of the 65 study patients are described in 
chapter 5 (table 5.2).
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Arterial compliance
Table 6.1 demonstrates the correlation between right and left common 
carotid arterial compliance measurements. There was excellent 
correlation between sides thus the results are presented as the mean of 
the two arteries. The coefficient of variation for mean arterial diameter 
measurement in a random sample of 20 patients from the study was 
4.2%.
Carotid arterial compliance results are shown in table 6.2. Arterial 
diameter was significantly greater in both hypertensive groups 
compared to the normotensives and was associated with a reduction in 
distensibility and rise time. The distensibility coefficient was 
significantly lower in both hypertensive groups compared to normal 
reflecting an increase in arterial stiffness (and a decrease in 
compliance).
Adjusting for the blood pressure at the time of ultrasound allows the 
pressure-strain elastic modulus (Ep) to be calculated and this was also 
significantly higher in subjects with either form of hypertension. There 
was no significant correlation between compliance data and age in each 
patient group, however the age range in each group was deliberately 
restricted to allow between group comparisons.
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Compliance
parameter
Mean
right
Mean
left
R P CV
Distensibility (pm) 730 ± 239 720 ± 256 0.931 <0.001 12.8
Diameter (mm) 6.05 ± 0.85 6.04 ± 0.84 0.933 <0.001 5.1
Rise time (ms) 134 ± 30 129 ±32 0.839 <0.001 13.4
Table 6.1
Correlation between right and left carotid compliance parameters 
(mean ± SD)
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Persistent White coat Normal p
Minimum 6.31 ±0.70* 6.30 ±0.88* 5.56 ±0.79 <0.005
diameter (mm)
Absolute 0.67 ± 0.25* 0.67 ± 0.26* 0.84 ± 0.23 <0.05
distension (mm)
% Distensibility 11.4 ±3.8* 11.3 ±4.0* 15.0 ±4.5 <0.005
Rise time (ms) 122 ± 18* 122 ±27* 149 ±27 <0.001
Ep(kPa) 4.64 ± 1.47* 4.36 ±2.12* 2.89 ± 1.07 <0.01
Distensibility 2.84 ± 0.09* 3.39 ±0.16* 4.37 ±0.14 <0.005
|Q-2kPa-l
Stiffness index 4.53 ± 1.38* 4.32 ± 1.90* 3.27 ± 0.95 <0.05
Table 6.2. Carotid arterial compliance (mean ±  SD) 
* significant difference compared to normotensives.
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Correlations with echocardiographic parameters
Table 6.3 lists Pearson’s correlation coefficients for echocardiographic 
predictors of distensibility parameters. Univariate analysis suggested 
significant associations between arterial distensibility and left 
ventricular end systolic and diastolic diameters (LVEDD, LVESD), 
posterior wall and septal thickness in diastole (LVPWd, IVSd), E 
velocity and isovolumetric relaxation time (IVRT). Multiple regression 
analysis confirmed that the only significant relations were in fact with 
LVEDD (p=0.025) and IVRT (p=0.005). No echocardiographic 
measurement was significantly related to arterial diameter.
Correlations with blood pressure measurements
Table 6.4 lists Pearson’s correlation coefficients for blood pressure 
predictors of arterial compliance measures. The most statistically 
significant associations were between arterial diameter and blood 
pressure measurements obtained during the ultrasound examination 
and calculated from the daytime ambulatory monitoring. Overall 
arterial diameter was directly related to the level of blood pressure. 
Conversely, there were generally negative associations between blood 
pressure and carotid arterial rise time.
Multiple regression analysis confirmed persisting correlations between 
arterial diameter and clinic systolic blood pressure (p=0.010) but not
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for diastolic pressure (p=0.359). There was a similar pattern for 
daytime ambulatory blood pressure averages (p=0.019 for systolic and 
p=0.880 for diastolic daytime averages). Rise time was correlated with 
the diastolic blood pressure measurements obtained during the 
ultrasound examination (p=0.530, 0.280 for systolic and diastolic 
pressures respectively) and during daytime monitoring (p=0.986, 0.046 
for systolic and diastolic daytime averages respectively).
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Echocardiographic
parameter
Mean
distensibility
Mean
diameter
Mean rise 
time
r P r P r P
IVSs 0.085 0.536 0.163 0.236 -0.040 0.773
IVSd 0.197 0.150 0.068 0.624 -0.026 0.848
LVPWs 0.035 0.798 0.223 0.102 0.074 0.589
LVPWd 0.210 0.123 0.161 0.239 -0.012 0.928
LVEDD 0.279 0.038 0.044 0.749 0.047 0.731
LVESD 0.341 0.010 0.083 0.542 -0.019 0.889
E 0.346 0.007 0.034 0.796 0.261 0.044
A 0.130 0.323 0.156 0.235 0.038 0.772
E dec 0.087 0.508 0.194 0.138 -0.027 0.836
A dec -0.054 0.682 -0.015 0.912 -0.065 0.620
IVRT 0.352 0.006 0.087 0.507 -0.063 0.630
E:A ratio -0.008 0.952 0.038 0.784 0.072 0.607
Table 6.3 Pearson’s correlation coefficients fo r  echocardiographic 
predictors o f  distensibility parameters.
Key to abbreviations:
IVSs, IVSd interventricular septum in systole or diastole 
LVPWs, LVPWd left ventricular posterior wall in systole or diastole 
LVEDD, LVESD left ventricular end diastolic or systolic diameter 
E early velocity of ventricular filling 
A active or atrial velocity of ventricular filling 
E dec E velocity deceleration time;
A dec A velocity deceleration time 
IVRT isovolumetric relaxation time 
E:A ratio ratio of E and A velocities
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Blood pressure parameter Distensibility Diameter Rise time
r P r P r P
Clinic Systolic -0.165 0.219 0.511 <0.001 -0.347 0.008
Pressure Diastolic -0.302 0.022 0.419 0.022 -0.436 0.001
Daytime Systolic -0.094 0.475 0.463 <0.001 -0.295 0.022
Average Diastolic -0.252 0.052 0.366 0.004 -0.386 0.002
Daytime Systolic -0.126 0.367 0.277 0.045 -0.232 0.094
Load Diastolic -0.245 0.062 0.274 0.036 -0.315 0.015
Night time Systolic -0.038 0.771 0.308 0.017 -0.166 0.205
average Diastolic -0.183 0.162 0.290 0.025 -0.285 0.027
Night time Systolic -0.005 0.977 0.386 0.017 -0.176 0.290
load Diastolic 0.061 0.737 -0.010 0.956 0.080 0.660
Table 6.4 Pearson’s correlation coefficients fo r  blood pressure 
predictors o f  mean compliance parameters
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DISCUSSION
This sub-study has demonstrated similar abnormalities of arterial 
elasticity in both persistent and white coat hypertensives. The 
persistent hypertensives had larger arteries than the normotensives as
1 f \  7 f ihas been previously described, ’ however the white coat 
hypertensives also had larger arteries. Although these abnormalities 
might simply reflect higher blood pressures at the time of the 
ultrasound examination the differences persisted after calculating the 
pressure strain elastic modulus, stiffness index and the distensibility 
coefficient which, mathematically at least, take account of blood 
pressure. Overall these vascular abnormalities represent a reduction in 
arterial compliance which normally provides elastic recoil during left 
ventricular contraction. This is thought to increase pulse pressure as a 
consequence and accelerate both the development of cardiac 
hypertrophy and the progression of atherosclerosis.56,57,76,164
As previously outlined it is not possible, other than by statistical 
means, to control for differences in blood pressure at the time of 
measurement in the white coat hypertensives since manipulation of 
blood pressure would itself change arterial compliance. This explains 
the need to represent arterial function by calculating multiple 
parameters since no single expression can adequately describe the
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mechanical properties of an artery throughout the cardiac cycle. The 
stiffness index has been described in previous studies of both muscular 
(eg, brachial) and elastic arteries (eg, carotid, femoral and the 
abdominal aorta) and, although wide variations were found in the 
brachial artery in response to changes in sympathetic tone, the index 
remained relatively constant in the carotid artery.44
The results also demonstrate links between abnormal arterial function
and abnormal left ventricular diastolic function. In particular, the
relations between LVEDD, IVRT and arterial distensibility persisted
despite correction for other echocardiographic measures. It is
interesting, however, that an increase in LVEDD was associated with
an increase in distensibility, rather than an inverse relationship. Cardiac
failure attributable to systolic left ventricular dysfunction is associated
with a decrease in arterial compliance14,39 but in this condition there is
1 ^significant peripheral vasoconstriction. It is possible, therefore, that 
the left ventricle in hypertension dilates as a secondary response to 
increased vascular stiffness, hence the positive association. The 
association between IVRT and arterial stiffness similarly suggests that 
left ventricular dysfunction could develop as a secondary phenomenon 
in hypertension. This obviously requires further research in 
longitudinal studies.
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In conclusion, there are two important aspects to these results. The first 
is the demonstration of vascular abnormalities in white coat 
hypertensives, similar to those found in persistent hypertensives. The 
second is the close association between diastolic left ventricular 
dysfunction and vascular compliance abnormalities.
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CHAPTER 7 DOPPLER ULTRASOUND
Carotid arterial pulsatility in hypertension 
Background
The clinical consequences of untreated hypertension have long been 
recognised with an increased risk of vascular complications 
particularly in the cerebral and coronary circulation.152,166,167 Systolic 
hypertension is thought to cause arterial damage through repeated 
mechanical cyclic strain which leads to fibrotic or hyaline degeneration 
in the media of large arteries.12,46 Such degeneration decreases arterial 
elasticity and increases the stiffness of the arterial bed. This has 
significant consequences for left ventricular strain and is associated 
with an increase in left ventricular mass and an increase in systolic 
blood pressure partly because of the rapid return of reflected pressure 
waves from the periphery during systole (rather than diastole) as
fiC\ lf\ 1reviewed in Chapter 2. Previous work ’ ’ by other research workers 
confirmed an increase in intima-medial thickness (IMT) in both large 
and medium sized arteries (carotid and radial). In addition to these 
structural abnormalities, it has also been shown that carotid artery 
compliance is reduced, as demonstrated earlier in chapter 6 and in
1 f \  7 ^  7 7  1 A Qwork by others. ’ ’ 5 However, the consequences and possible 
predictive factors for decreased arterial compliance in the carotid
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arteries require to be evaluated further to identify the nature of the 
mechanical strain.
Measurement of carotid arterial blood flow velocity using pulsed wave 
Doppler ultrasound is a convenient non-invasive method of 
determining intravascular blood flow properties. While it is only 
possible to determine actual blood flow (in ml/min) if the arterial 
diameter is known throughout the cardiac cycle, blood flow velocity 
gives an indication of the mechanical stress placed on the arterial wall. 
It is possible to calculate a pulsatility index170 which provides an 
indication of the tensile stress sustained by the artery during systole. In 
addition it is possible to calculate a measure of parietal stress (as 
defined in chapter 4) in the area of brain supplied by the artery.171
It is interesting to note that systolic rather than diastolic hypertension 
correlates more closely with the cerebrovascular consequences of 
hypertension49 although many of the large hypertension trials used
1 ^9diastolic blood pressure as an inclusion criterion. The SHEP study
confirmed significant benefit from treating isolated systolic 
hypertension in the elderly and work on vascular compliance,
1 7  5 7particularly by O’Rourke, ’ suggests that systolic blood pressure 
control should be the primary target of antihypertensive treatment.
The aim of this study was to determine the carotid arterial blood flow 
velocities in the persistent, white coat and normotensives described in
93
chapter 5. From these velocities we intended calculating measures of 
mechanical arterial strain in an attempt to determine the correlations 
with blood pressure measurements and the possible future development 
of clinically significant atherosclerosis.
Methods
The subjects in this section are described in chapter 5. The same 
inclusion and exclusion criteria apply. In addition to the clinical details 
presented, haematocrit also was measured in these subjects since 
previous studies suggested an increase in haematocrit in hypertensive 
subjects which influences cerebral blood flow.172,173 Carotid Doppler 
ultrasound was performed as described in chapter 4.
Calculations
Pulsatility index170 was calculated as:
Systolic - diastolic velocities 
Mean velocity
Parietal stress171 was calculated according to Lame’s approximation for 
the cylindrical structures of Laplace’s law:
Mean Blood pressure x Carotid artery radius 
Arterial wall thickness
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Blood pressure was converted to kPa for this calculation.
Statistical analysis
Analysis of variance with Fisher’s pairwise comparisons was 
performed to compare the patient groups. Pearson’s correlation 
coefficients were calculated for right and left velocity comparisons and 
to assess predictors of pulsatility index before multiple regression 
analysis. A p value <0.05 was considered significant
Results
Patient characteristics are described in chapter 5. Mean haematocrit in 
the persistent, white coat and normotensives was 0.43±0.03, 
0.42±0.03, 0.41 ±0.03 respectively (p=0.068 ANOVA).
Ultrasound measurement
Reproducibility
Reproducibility was assessed on a random sample of 20 subjects. The 
coefficient of variation was 6.3% for common carotid velocity 
measurements (r=0.958, r =0.918). There was no significant difference 
between the right and left sides for any of the blood flow velocity 
measurements (see table 7.1) although the correlation between right
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Right Left r r2
Systolic Common carotid 47.5 ± 14.8 46.7 ± 10.5 0.628 0.394
Internal carotid 43.6 ± 26.3 38.1 ±21.6 0.719 0.517
External carotid 49.7 ± 20.8 48.6 ± 15.0 0.446 0.199
Diastolic Common carotid 10.2 ±4.2 10.9 ±3.8 0.668 0.446
Internal carotid 15.0 ±8.3 13.3 ±6.9 0.621 0.386
External carotid 8.0 ± 5.3 7.5 ±3.0 0.171 0.029
Table 7.1
Comparison o f  right and left carotid blood flow  velocities in cm/sec 
(mean ± SD)
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and left external carotid velocities was poor. Correlations were good 
for the internal and common carotid segments. Analysis was performed 
with the mean of the right and left measurements.
Patient groups
A comparison of the blood flow velocities in the three patient groups is 
shown in table 7.2 and illustrated in figures 10 and 11. There were no 
significant differences between groups for the common carotid artery 
measurements. However, systolic velocities in the internal carotid 
artery were significantly higher in the persistent hypertensives (42.7 ± 
14.2 cm/sec) compared to both white coat (35.5 ± 9.7 cm/sec) and 
normotensives (33.4 ± 8.3 cm/sec). In addition, pulsatility indices were 
significant greater in both the persistent (1.24 ± 0.19) and white coat 
hypertensives (1.20 ± 0.25) compared to normal (0.96 ± 0.22).
Multiple regression analysis (table 7.4) confirmed a significant 
association with systolic blood pressure measurement obtained during 
the ultrasound but not for the others.
97
Ve
loc
ity
 
(c
m
/se
c)
60 -| 
50 - 
40 - 
30 -
*
systolic
20  -  
10 -  
0
{ I
P e r s i s t e n t W h i t e  c o a t
l
diastolic
H y p e r t e n s i v e
Figure 10. Comparison of internal carotid artery velocities
*significant difference compared to white coat and normotensive groups, p=0.019
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Figure 11. Comparison of pulsatility indices
* significant difference compared to normal, p=0.001
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Persistent White coat Normal p
Common Systolic 49.5 ± 12.4 47.0 ± 12.0 48.0 ± 10.5 0.775
Carotid Diastolic 11.4 ±2.8 10.2 ±3.7 11.3 ±3.7 0.398
Mean 24.1+5.3 22.5 ±5.7 23.5 ±5.3 0.587
PI 1.57 ±0.24 1.65 ±0.28 1.56 ±0.24 0.392
Internal Systolic 42.7*± 14.2 35.5 ±9.7 33.4 ±8.3 0.019
Carotid Diastolic 13.8 ±5.4 12.0 ±4.0 13.9 ±3.8 0.190
Mean 23.4 ±8.1 19.8 ±5.4 20.4 ± 4.8 0.121
PI 1.24 ±0.19 1.20 ±0.25 0.96 ± 0.22 0.001
External Systolic 53.4° ± 14.1 44.2 ± 11.4 47.1 ± 13.2 0.063
Carotid Diastolic 7.9 ±2.2 7.0 ± 1.8 8.2 ±3.4 0.208
Mean 23.0° ±5.7 19.4 ±4.5 21.1 ±5.7 0.073
PI 1.97 ±0.19 1.91 ±0.22 1.85 ±0.35 0.347
Table 7.2 Comparison o f  blood flow  velocities in the patient groups 
(mean ± SD)
*significant difference compared to normal 
0significant difference compared to white coat hypertensives
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Common
carotid
Internal
carotid
External
carotid
P
Age 0.215 0.117 0.241 0.310
BMI 0.253 0.088 0.118 0.560
BP during - 0.077/ 0.498/ -0.010/ 0.001/
ultrasound 0.269 0.414 0.362 0.001
Daytime 0.027/ 0.368/ 0.209/ 0.002/
average BP - 0.075 0.312 - 0.068 0.011
Night time - 0.054/ 0.245/ 0.166/ 0.050/
average BP - 0.077 0.229 -0.010 0.067
Diameter 0.220 0.320 0.099 0.010
Distensibility 0.211 0.146 0.152 0.251
Table 7.3 Pearson’s correlation coefficients fo r  predictors o f  
pulsatility index in the common, internal and external carotid arteries.
Blood pressure indices presented as systolic/diastolic, p  refers to 
significance o f  association with internal carotid pulsatility.
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r SD t Ratio P
Systolic BP during ultrasound 0.0058 0.0029 2.02 0.048
Diastolic BP during ultrasound 0.0034 0.0040 0.86 0.392
Daytime systolic 0.0024 0.0068 0.35 0.725
Daytime diastolic -0.0015 0.0090 -0.16 0.871
Night time systolic -0.0013 0.0060 -0.21 0.834
Night time diastolic - 0.0006 0.0085 -0.07 0.946
Table 7.4 Multiple regression o f  internal carotid pulsatility predictors
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Discussion
This sub-study has demonstrated significant abnormalities in internal 
carotid blood flow velocities in persistent and white coat hypertensive 
patients.
Systolic hypertension is associated with an increased risk of both 
haemorrhagic and ischaemic stroke.49,174,175 Treatment of hypertension 
has been shown to markedly reduce the incidence of haemorrhagic 
stroke which is thought to be due to arteriolar disease176'9 but has a 
smaller effect on the incidence of ischaemic stroke due to 
atherosclerosis.
Internal carotid artery atherosclerosis is associated with 
cerebrovascular injury both through embolism from ruptured plaque 
and through ischaemia due to diminished blood flow. These results 
show an increased mechanical strain in the wall of the internal carotid 
artery but also indicate an increased level of parietal stress in the 
distribution territory of the artery. Parietal stress refers to the 
mechanical strain placed on the arterioles and smaller blood vessels. 
Reduction of blood pressure with antihypertensive drugs is known to
i sn i fi")alter blood flow velocities in the carotid arteries " but studies have 
yet to be performed examining for the effects of treatment on parietal 
stress.
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Our results suggest two important possible clinical consequences. The 
first is that the abnormalities of blood flow velocities within the 
internal carotid artery may respond to treatment. The second is that 
white coat hypertensives were found to have significant flow velocity 
abnormalities, albeit to a lesser degree than the persistent 
hypertensives, which might also be amenable to treatment.
Our results are consistent with a previous study which compared blood 
flow velocities in hypertensives and matched normals.171 Although an 
increase in parietal strain was found in their hypertensive group there 
was no increase in either pulsatility index or arterial diameter. This is 
surprising since other studies of large arteries in hypertensives,
including that described in chapter 6, have found significantly higher
00  0 ( \diameters than in normotensives ’ but mean arterial velocities rather 
than systolic or diastolic velocities were presented. In this published 
paper the mean internal carotid artery velocity in hypertensives was 
found to be higher compared to normotensives (mean 37.5 ± 9.1 
versus 32.7 ± 3.9 cm/s, p<0.02). Our results do not show any 
difference in mean velocities. However our patients were older (mean 
59 years compared to 49 years) and had higher blood pressures during 
the ultrasound examination (mean 165/107 compared to 161/99 in 
their hypertensive group). Arterial stiffness and blood pressure 
increase with age and this may partly explain the difference in results.
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In addition, only a subgroup of the study population were studied 
using Doppler ultrasound (30 hypertensive and 20 normotensive 
subjects) and the criteria for diagnosing hypertension were not stated.
In conclusion, abnormalities of internal carotid artery pulsatility were 
found in hypertensive patients, whether persistent or white coat, which 
correspond to an increase in mechanical strain in the arterial wall and 
an increase in parietal stress within the brain. These abnormalities are 
likely to be related to the pathogenesis of both atherosclerotic and 
haemorrhagic cerebrovascular disease. The specific effects of 
antihypertensive treatment on parietal stress require further evaluation, 
as do the differential effects of the various classes of antihypertensive 
drugs.
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CHAPTER 8 B-MODE ULTRASOUND
Carotid intima-medial thickness in hypertension 
Background
This section describes the use of high resolution B-mode ultrasound to 
measure carotid wall thickness in an extension of the study of white 
coat hypertensives described in chapters 5. Having already 
demonstrated functional abnormalities of cardiac and large vessel 
function, the next step was to attempt to identify structural 
abnormalities in these subjects. This further study includes additional 
patients recruited during the 12 months following the original study.
Carotid intima-medial thickness (IMT) has been identified as a marker 
of cardiovascular disease corresponding to the presence of coronary 
artery disease (table 8.1), peripheral arterial disease (table 8.2) and 
there is increasing evidence that IMT can be used to predict the future
1 TO 1 S'!development of myocardial infarction and stroke. ’
Arterial wall thickening is known to develop in untreated 
hypertensives60 and several large multicentre studies are underway to 
examine the potential benefit of antihypertensive treatment in 
preventing the progression of intima-medial thickening. This includes 
the European Lacidipine Study on Atherosclerosis, the source of our
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patients, which is due to report its four year follow-up results in 1999. 
Intima-medial thickening can be detected early in disease processes 
and may function as an early or surrogate marker for longterm 
cardiovascular morbidity and mortality. Increased IMT has been
1 TOdescribed in hypertension in the common carotid, femoral and radial 
arteries. The microscopic changes associated with increased IMT are 
unclear but are thought to represent diffuse atherosclerosis and this is 
consistent with the increased risk of myocardial infarction seen in a
1 RTrecent prospective study. The other possibility is that intima-medial 
thickening is caused by smooth muscle hyperplasia rather than 
atherosclerosis and there are close associations between IMT and 
systolic blood pressure which causes vessel wall hypertrophy. IMT is 
also strongly correlated with age and was found to increase by 0.01
1 fiAmm/year in both male and female populations. This is important in 
the design of cross sectional studies which should be matched for age. 
Other factors which have been shown to influence IMT include 
hypercholesterolaemia, smoking, LDL cholesterol, systolic blood 
pressure, diabetes, triglycerides, fibrinogen, pulse pressure, uric acid, 
type A personality score, copper, platelet aggregability, low selenium 
levels, waist-hip ratio, body mass index, insulin, ACE genotype, ACE
1 TOactivity and saturated fat intake.
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Study Reference Association
Crouse et al 1986 197 Obstructive CAD associated with increased 
carotid IMT
Chambers & Norris 
1986
198 Carotid atherosclerosis associated with 
increased risk of clinical CAD
Rubens et al 1988 199 Obstructive CAD associated with increased 
carotid IMT
Howard et al 1990 200 Carotid atherosclerosis present in majority of 
patients with symptomatic CAD
Craven et al 1990 201 Obstructive CAD associated with increased 
carotid IMT especially >50 years
Wofford et al 1991 202 B-mode changes predicted coronary 
angiography findings
Scudlova et al 1991 203 85% of patients with myocardial infarction 
have carotid atherosclerosis
Salonen et al 1991 183 Carotid wall morphology predicts future risk 
of angina and myocardial infarction
Salonen et al 1994 204 Carotid IMT and plaque associated with 
clinical CAD and CAD risk factors
Geroulakos et al 
1994
194 Relation between IMT and number of 
coronary arteries involved
Burke et al 1995 
(ARIC)
205 Carotid IMT and prevalence of symptomatic 
CAD in middle aged adults
Crouse et al 1995 193 Quantitative associations between B-mode 
IMT and angiographic CAD severity
Table 8.1
Association between carotid IM T and coronary artery disease (CAD).
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Study Reference Association
Spurk et al 1989 206 Association between carotid wall thickening 
and peripheral vascular disease (pressure 
index)
Pujia et al 1989 207 Direct correlation between peripheral and 
carotid atherosclerosis (r=0.3, p<0.001)
Wendelhag 1993 208 Correlation between carotid IMT and presence 
of femoral plaque
Wilt et al 1993 
The MIDAS Study
209 Carotid plaque thickness related to presence of 
peripheral vascular disease
Bots et al 1993 195 Common carotid IMT in elderly women 
associated with abdominal aortic calcification 
on X-ray (although ultrasound performed up to 
5 years after X-ray)
Bots, Hofman & 
Grobbee 1994
210 Common carotid IMT correlates with 
ankle/arm pressure index
Joensuu et al 1994 196 Correlations and determinants of femoral and 
carotid IMT
Bots et al 1996 
The Rotterdam Study
211 Common carotid IMT associated with 
indicators of peripheral vascular disease 
including ankle/arm index and femoral IMT
Table 8.2
Association between carotid IM T and peripheral vascular disease
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Such thickening also occurs in dyslipidaemic states and
hypercholesterolaemic children have been shown to have increased 
IMT. Furthermore, intima-medial thickening has been shown to be
1 RAtreatable with lipid lowering therapy.
The fact that serial measurements can detect the progression of IMT in 
clinical studies gives an indication of the levels of accuracy and 
reproducibility possible with high resolution B-mode ultrasound. 
Guidelines have been formulated to maximise reproducibility when
1 8 7  8 100 1 0 7measuring IMT ' ’ ’ and these have been adopted in the
multicentre studies via the development of rigorous measurement 
protocols.
High resolution B-mode ultrasound measurement of IMT has been
77 ioi #validated against histological specimens ’ with a correlation 
coefficient of 0.76 to 0.82 (p<0.001) in these early studies. In addition 
it was confirmed that the echogenic lines in the B-mode scan did 
indeed correspond to the intimal and medial layers.
Our aim was to use high resolution B-mode ultrasound to examine the 
common carotid arterial segment for IMT in an extension of the study 
of persistent, white coat and non-hypertensive patients described in 
chapters 5. We chose to concentrate on the common carotid artery 
rather than examining the internal carotid artery and bifurcation since 
pilot work suggested that over 35% of our subjects would present
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technical difficulty when aligning the ultrasound probe to give an 
adequate view of these segments. This was consistent with previous 
work from the large multicentre Atherosclerosis Risk in Communities
1 fiQ(ARIC) study where 41% of carotid bifurcations and 59% of internal 
carotid arteries could not be measured reliably. The problem of missing 
data in such a large study can be overcome (over 14,106 baseline 
ultrasound examinations) but would be seriously damaging to a smaller 
study. Unless the ultrasound probe can be aligned perpendicularly to 
the arterial segment to be studied it is impossible to demonstrate the 
intima-medial segment reliably.
Methods
Subjects were recruited using the inclusion and exclusion criteria 
described in chapter 5. Recruitment to the study continued in a 
consecutive referral manner and blood pressure measurement was 
performed in a standard fashion as previously described (page 5.9).
Ultrasound examination was performed as described in chapter 4. 
Statistical analysis
Blood pressure load was defined as the percentage of ambulatory 
systolic measurements of 160 mmHg or more, or diastolic of 90 mmHg 
or more. A % test was used to test for sex distribution between groups.
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Analysis of variance with Fisher’s pairwise comparisons was used to 
determine between group differences. Pearson’s correlation 
coefficients were used to summarise carotid IMT predictors before 
multiple regression analysis of predictors with significant correlations. 
A p value of <0.05 was considered significant.
Results
A total of 95 subjects were studied. Their clinical details are 
summarised in table 8.3 (below). There were no significant differences 
between groups in terms of sex distribution, age, weight, height, or 
heart rate. However, the persistent hypertensives had significantly 
higher creatinine levels (92 ±17 compared to 80 ± 16 and 79 ± 17 
pmol/1, p=0.004) and triglycerides (1.98 ± 1.09 compared to 1.56 ± 
0.74 and 1.31 ± 0.72 respectively, p=0.013) compared to both white 
coat and normotensives. Plasma markers including cholesterol, 
glucose, fibrinogen and lipoprotein (a) were similar in the three groups.
Blood pressures
The blood pressure profiles are shown in figures 13 and 14. By 
definition the persistent and white coat hypertensives had higher blood 
pressures at the clinic compared to normotensives (p<0.001). There 
was no significant difference between white coat and normotensives in 
terms of ambulatory daytime and night time averages.
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Persistent White coat Normal P
Male/female 21/12 17/19 10/16 NS*
Age (years) 58 ±7 60 + 8 60 ± 8 0.493
Heart rate (bpm) 67 ± 9 64 ± 7 64 ± 8 0.529
Weight (kg) 79 ± 17 75 ± 16 76 ± 17 0.795
Height (cm) 167 ± 7 165 ± 9 172 ± 11 0.217
Creatinine (|imol/l) 92 ± 17° 80 ± 16 79 ± 17 0.004
Cholesterol (mmol/1) 6.1 ± 1.0 5.8 ±0.9 5.7 ± 1.1 0.297
Triglycerides (mmol/1) 1.98 ± 1.09° 1.56 ±0.74 1.31 ±0.72 0.013
Glucose (mmol/1) 5.71 ±1.42 5.49 ± 1.01 5.32 ± 0.63 0.388
Fibrinogen (u/1) 297 ± 80 304 ± 84 322 ± 77 0.480
Lp(a) 20.0 ± 16.3 23.4 ± 17.8 22.0 ± 15.6 0.719
Table 8.1
Comparison between persistent, white coat and non hypertensives 
(mean ± SD)
*p>0.10 ( t f  test), 0significant difference compared to normal
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Figure 13. Daytime blood pressure measurements.
*p<0.001 compared to normotensive patients.
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Figure 14. Night time blood pressure measurements.
*p<0.001 compared to normotensives.
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Sex differences
While there were no significant differences between groups in terms 
of sex distribution it was important to exclude small differences which 
might potentially explain patterns of IMT described below. The entire 
study population therefore was analysed in terms of sex (table 8.4).
This confirmed that males had higher weight, height, creatinine and 
average diastolic blood pressures. Females had significantly higher 
cholesterol levels. However there was no significant sex-related 
difference in carotid IMT (p=0.101).
Carotid IM T
Reproducibility was assessed by comparing results of IMT values 
from the two ultrasound examinations available for each subject in 50 
randomly selected cases. The mean IMT measurement for exam 1 was 
0.632mm ± 0.175 and for exam 2 was 0.617 ± 0.177 giving a 
correlation coefficient r=0.869 and r =0.755.
There was no significant difference between right and left IMT 
measurements. The overall mean right IMT was 0.683 ± 0.193mm and 
that for the left was 0.6991 ± 0.236.
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Male Female p
Weight (kg) 86.9+11 65.7+ 13 <0.001
Height (cm) 174 ± 7 161 ±5 <0.001
Glucose (mmol/1) 5.56+1.02 5.42+1.10 0.515
Creatinine (pmol/1) 96+ 18 73 + 13 <0.001
Cholesterol (mmol/1) 5.41 ± 0.98 5.94+1.02 0.046
Triglycerides (mmol/1) 1.60 + 0.94 1.53 + 0.81 0.726
Mean IMT (mm) 0.705 + 0.215 0.645 + 0.151 0.101
Fibrinogen (u/1) 306 ± 79 311 ±80 0.796
Lp(a) (u/1) 20.5+15.1 28.2 ± 27.5 0.111
Day load (systolic) % 63 ±30 54 + 32 0.175
Day load (diastolic) % 56 + 29 50 + 28 0.003
Night load (systolic) % 48 ±33 40 + 32 0.306
Night load (diastolic) % 36 + 28 23+1 9 0.054
Table 8.4 Comparison o f  male and female characteristics
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The correlation coefficient for right and left sided measurements was 
0.832 (r2=0.692) therefore the data are presented as the mean of the 
right and left IMT values.
Persistent hypertensives had the highest IMT of 0.760 ± 0.247mm, 
white coat hypertensives had an intermediate value of 0.695 ± 
0.200mm, and normotensives 0.583 ± 0.100mm (see figure 15). Both 
persistent and white coat hypertensives IMT values were significantly 
higher than normotensives (p=0.004 ANOVA with Fishers pairwise 
comparisons).
Further analysis of IMT predictors was performed and is shown in 
table 8.5.
The correlation coefficients suggest significant links with age, day and 
night systolic mean pressure, daytime systolic load, and day and night
pulse pressure. However, multiple regression analysis (table 8.6, 
below) confirms that these weak associations were no longer 
significant after controlling for age.
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R R2 P
Age 0.231 0.053 0.019
Height 0.211 0.045 0.204
Weight 0.118 0.014 0.456
Day systolic 0.259 0.067 0.009
Day diastolic 0.124 0.015 0.213
Night systolic 0.303 0.092 0.002
Night diastolic 0.179 0.032 0.074
Day load (systolic) 0.213 0.045 0.034
Day load (diastolic) 0.126 0.016 0.209
Night load (systolic) 0.324 0.105 0.008
Night load (diastolic) 0.031 0.001 0.819
Day pulse pressure 0.265 0.070 0.007
Night pulse pressure 0.319 0.102 0.001
Fibrinogen 0.091 0.008 0.380
Lp(a) -0.117 0.014 0.248
Table 8.5
Pearson’s correlation coefficients fo r  common carotid IM T predictors
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Figure 15. Comparison of carotid intima-medial thickness.
* significant difference compared to normotensives (see text)
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Partial correlation SD p 
coefficient
Age 0.0052 0.0026 0.048
Day systolic 0.0001 0.0035 0.763
Night systolic 0.0016 0.0032 0.619
Day pulse pressure -0.0016 0.0061 0.799
Night pulse pressure 0.0026 0.0062 0.679
Table 8.6
Multiple regression analysis o f  common carotid IM T predictors
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Discussion
The most significant finding of this study is the demonstration of 
arterial wall thickening in white coat hypertensives.
The persistent hypertensives had evidence of target organ damage with 
significantly higher serum creatinine levels compared to both white 
coat and normotensives. It is interesting to note that carotid wall 
thickening occurred without any other sign of target organ damage in 
the white coat hypertensives. Echocardiographic results from chapter 5 
confirm that there was no increase in left ventricular mass in the 
earlier cohort of white coat hypertensives. Previous work has shown 
close correlations between increasing IMT in hypertensives and LV 
mass and significant associations with left ventricular posterior wall 
thickness, end diastolic diameter and relative wall thickness.76 This 
study suggests that early arterial wall thickening may develop before 
left ventricular structural changes and that IMT measurements could 
be used as an early predictor of end organ damage and thus be used to 
direct the most effective use of antihypertensive therapy. However, 
further research is required to substantiate the association of intimal- 
medial thickening and cardiovascular morbidity or mortality.
There is convincing evidence that untreated hypertension causes an 
increase in vascular mass because of arterial wall thickening. This has
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been shown in medium sized muscular arteries such as the radial 
artery168 as well as larger more elastic carotid arteries.60 Such wall 
thickening is likely to represent an adaptive response to hypertension 
to reduce media tensile stress.191 However, wall thickening also 
decreases arterial compliance by increasing vessel stiffness and this is 
implicated in the development of left ventricular hypertrophy, 
atherosclerosis and systolic hypertension.11 Thus intima-medial 
thickening exacerbates the underlying driving force of systolic 
hypertension which was found to be one of the strongest predictors of 
IMT in our study (in univariate analysis) and in work by other 
groups.192'196
Treatment with lipid lowering drugs halts the progression of IMT seen 
in untreated hypercholesterolaemic individuals (mean 0.018 mm/year) 
and after one year of treatment reduces IMT from baseline to reach a
1 fiAplateau. It is probable that wall thickening increases in response to 
hypertension or hypercholesterolaemia to reach a threshold before the 
development of atherosclerotic plaque. IMT is unlikely to increase in a 
linear manner indefinitely. This is consistent with the widely accepted 
concept of the pathogenesis of atherosclerosis from foam cells to fatty 
streaks, discrete plaque development and finally plaque rupture and 
subsequent thrombus formation.
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Carotid IMT corresponds with disease in other arterial beds and it is 
reasonable to assume that the adaptive changes seen in the carotid 
arteries in our study are also present in other vessels such as the aorta, 
femoral and coronary arteries.
While convincing long-term follow up studies are required to 
determine the predictive value of carotid IMT in cardiovascular 
disease there is accumulating evidence to support the hypothesis that it
/A  n/r 1 /ro
is a surrogate marker of early end organ damage in hypertension ’ ’
1 f\and hypercholesterolaemia. ' Surrogate markers such as IMT may 
be valuable in future studies assessing treatment benefits because they 
reduce sample size and follow-up requirements in studies of 
cardiovascular disease.
Thus we have identified early structural abnormalities in patients with 
white coat hypertension: these abnormalities have been shown in some 
other studies to be correlated with cardiovascular morbidity and 
mortality, and this suggests that white coat hypertension may not be 
wholly innocent. Two unresolved issues remain; first, to demonstrate 
that IMT does consistently correspond with, and is predictive of, 
cardiovascular morbidity and mortality; and second, to show that 
treatment with antihypertensive therapy indeed causes a reduction in 
IMT. Large multicentre prospective studies are underway and are due 
to report in several years.
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CHAPTER 9 TRANSCRANIAL DOPPLER
Embolus detection in divers during decompression 
Introduction
This chapter describes the use of transcranial Doppler ultrasound 
(TCD) in commercial air breathing divers to detect right-to-left 
shunting, and to determine the incidence of bubbles in the cerebral 
circulation during decompression. It is the first published application 
of TCD monitoring in divers.
Background
Divers rely on decompression tables to maximise the dive duration at 
depth without resulting in decompression illness. These tables were 
first developed for the Royal Navy by Haldane in 1906 using animal
91 9models, such as the goat. The United States Navy proceeded to 
human experimentation in 1932 subjecting recruits to dives of 
increasing depth and duration and monitoring for complications by
91Tclinical examination and questioning. Many of the resulting tables 
were dangerous because there was a significant level of under­
reporting of symptoms by the divers and a lack of objective 
measurement of decompression risk. This led to considerable interest 
in developing objective techniques capable of determining which
126
individuals were at risk of decompression illness, and which could be 
used to monitor the response to recompression.
Spencer was the first to use Doppler ultrasound in divers over 20 years 
ago and his studies confirmed the presence of venous bubble signals in 
asymptomatic divers using decompression tables available at that 
time.85 Many other groups, including the United States Navy and the 
Royal Navy, conducted further research with ultrasound detectors 
aiming to develop decompression tables based on Doppler bubble 
counts which were thought to be directly related to the pathogenesis of 
decompression illness.214 However, studies failed to confirm a 
significant correlation between venous bubbles and the incidence or 
severity of decompression illness.215 This was disappointing and 
confirmed that decompression illness is a multifactorial condition 
which is more complicated than the development of nitrogen bubbles 
in venous blood. Circulating nitrogen bubbles have many harmful 
effects including mechanical disruption of tissue, obstruction of blood 
vessels, activation of leukocytes, endothelial cells and platelets, as well
* •  • 91as activation of coagulation and complement pathways. Models have 
shown that inert gas supersaturation and subsequent bubbling first 
occurs in the peripheral tissues and then in the veins. These venous 
bubbles are usually trapped by the lungs and resolve by diffusion into
• • 917the alveoli without adverse effect unless there is an overwhelming
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915quantity of gas or there is conduit for right-to-left shunting of blood 
and bubbles, such as a patent foramen ovale.
Patent foramen ovale
With widespread use of decompression tables it became clear that 
some individuals were more susceptible to decompression illness than 
others, despite identical dive characteristics for depth, duration,
910temperature and physical exertion. A case report by Wimshurst in 
1986 described the development of serious neurological decompression 
illness in a diver who had operated within the recommended 
decompression limits. Investigation revealed the presence of an atrial 
septal defect which was thought to be related to this individual’s 
symptoms. Although asymptomatic divers have detectable venous gas 
bubbles, the lungs usually dissipate such gas loads without harm. 
However, if a potential route is present between the venous and arterial 
systems then the lungs would be bypassed and arterial gas embolism 
would result. Shunting is more likely to occur when diving since
immersion in cold water increases right heart pressures relative to the
220 221left thus causing blood to cross from the right to left heart. ’
There are three main mechanisms implicated in the pathogenesis of 
decompression illness. These are arterial embolism, venous infarction 
and autochthonous bubble formation (the formation of bubbles within
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999 •tissues). These are described in detail elsewhere and are summarised 
below. Historically it was noted by Boycott et al (1908) and Bert 
(1878) that goats undergoing decompression developed both venous 
and arterial gas bubbles. Venous bubbles correlated poorly with the 
clinical manifestations of decompression illness, however animals with 
arterial bubbles almost invariably died. The histological appearances of 
spinal cord damage caused by experimental arterial embolism are 
different from those found in humans with clinical decompression 
illness. ’ The venous infarction hypothesis suggests that gas 
bubbles become trapped in the epidural vertebral venous plexus which 
is a large valveless low pressure system, thus increasing the chance of 
gas bubble formation, subsequent aggregation of bubbles before 
coalescence, and finally foaming. This results in coagulation and 
complement activation which causes a rise in venous pressure leading 
to spinal cord congestion and eventually infarction.
The venous infarction hypothesis helps to explain why the spinal cord 
is affected much more commonly than the brain in decompression 
sickness despite receiving a much lower proportion of the cardiac 
output. However, it is unlikely that bubbles would obstruct the entire 
venous plexus since it is a large system. One might expect a segmental 
pattern of obstruction with resultant clinical signs if parts of the system 
are affected but this does not always occur in practice.
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This difference may result from gas bubble formation in the peripheral 
tissues, the autochthonous bubble hypothesis. Animal experiments 
have shown that bubbles develop first in the peripheral tissues, then in 
the venous circulation before arterial bubbles finally appear. 
Autochthonous bubbles have been shown to develop preferentially in 
the white matter of the spinal cord and brain but these do not 
correspond histologically to all of the lesions seen in genuine cases of 
decompression sickness.
The fact that no theory alone can adequately explain the manifestations 
of decompression illness seen in humans suggests that it results from a 
combination of all three mechanisms with individual cases varying in 
the relative proportions of each. However, right-to-left shunting could 
increase the quantity of arterial nitrogen bubbles and this might be 
expected to increase the peripheral tissue nitrogen load. If this occurs 
in practice then a high proportion of individuals with decompression 
sickness would be expected to have a means of shunting from the right 
to left heart.
A recent review of decompression illness in amateur divers suggested 
that the majority of cases occurred in divers using recommended
• 199 • »decompression limits. Recent studies suggest a possible link 
between the presence of a patent foramen ovale (PFO) and subsequent 
decompression illness122,225,226 with a higher incidence of PFO being
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found in divers who had developed serious neurological 
decompression sickness. However, studies performed to date have 
been retrospective and cross-sectional in design and therefore are 
limited in their predictive value. The role of a PFO in decompression 
illness is far from clear and this led to the design of the study described 
below.
Techniques fo r  detecting shunting
Until recently the only non-invasive technique available for screening 
for right-to-left shunting was transthoracic echocardiography with 
peripheral contrast injection. As discussed earlier (chapter 3) this 
method has been shown to be less sensitive when compared with 
transoesophageal and transcranial ultrasound.123,124,228 Although 
transoesophageal echocardiography is the most sensitive method of 
detecting intracardiac shunting it is an invasive procedure unsuitable 
for screening otherwise healthy divers. TCD can be performed in 
almost any setting and offers higher levels of sensitivity with 
considerable convenience.
Diving practice
Commercial diving requires different equipment and techniques to the 
free swimming amateur SCUBA (Self Contained Underwater
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Breathing Apparatus) diver. Commercial pressures require that 
underwater time be maximised to allow divers to perform as much 
work as possible. While amateur divers monitor their own depth and 
dive duration, commercial divers monitor decompression procedures 
from the surface. The diver has a continuous air supply from a hose 
attached to a full face mask, compared to the goggles and mouth piece 
used by amateurs. Commercial divers commonly use two different 
decompression techniques. One technique (underwater decompression) 
involves halting the ascent near the surface (a decompression stop) and 
waiting for a recommended period, usually 10-20 minutes depending 
on the depth and duration underwater, allowing nitrogen to be released 
from the tissues and to be eliminated by the lungs. This technique is 
also used by amateur divers but is difficult to perform particularly if 
the water is cold, if there are underwater currents, or if there is a large 
swell which can make it impossible to remain at a constant depth. 
Surface decompression allows divers to ascend to the surface despite a 
decompression penalty, provided they then transfer immediately to a 
decompression chamber. They have less than 5 minutes to enter the 
chamber, a period known as the surface interval. They are then 
recompressed in the chamber and may breath 100% oxygen or 
mixtures of helium and oxygen before being decompressed to surface 
pressure at a controlled rate. The surface interval in decompression is
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potentially the most hazardous time for divers since they have incurred 
a decompression penalty and have considerable quantities of nitrogen 
in the blood and tissues. A further highly specialised technique is 
saturation diving where divers are compressed for periods of days or 
weeks before very slowly being decompressed at the end of the work 
period. This last technique has known hazards but is commonly used in 
deep diving practice.
This study involved monitoring the arterial circulation of divers who 
had been investigated for shunting. The aim was to determine whether 
gas bubbles were present in the cerebral circulation of those divers 
with shunting (through a PFO) during surface and underwater 
decompression.
Methods
20 divers taking part in a commercial diving training course at the 
Underwater Centre in Fort William were invited to give written 
informed consent to participate in this study which had ethics 
committee approval from the Western Infirmary (Glasgow) and the 
local committee in Lochaber. Three divers declined and were excluded. 
The remaining 17 were healthy males (age 21-34 years) with no 
significant past medical history and with normal cardiac and 
respiratory function as determined by clinical examination,
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transthoracic echocardiography and spirometry (see table 9.1). None of 
the subjects had a history of decompression sickness.
The divers continued the course which involved diving from two 
surface barges which supplied compressed air from the surface to their 
face masks. They performed training exercises at depth including 
rescue simulations, underwater searches and industrial engineering 
tasks. The dives generally were in cold water (6°C) and were physically 
demanding which, combined with the depths achieved, increases the 
risk of decompression illness. All dives were conducted according to 
the United States Navy diving tables.
The TCD machines were stationed on the barges and were powered by 
portable generators which developed 240V alternating current and 
incorporated surge suppression circuitry. TCD monitoring was 
performed on the divers after surfacing using an EME TC-2000 
(Nicolet, Warwick, UK) with a 2 MHz probe placed over the right 
temporal bone. The right middle cerebral artery was identified at a 
depth of 46-54 mm and Doppler waveforms were stored digitally on 
hard disc for subsequent analysis as described in chapter 4.
Monitoring was performed during the surface interval for as long as 
possible in dives requiring surface decompression. For safety reasons 
this usually allowed 1-2 minutes of monitoring to keep the total 
interval to less than 3/4 minutes to minimise the risk of decompression
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illness. The remaining VA minutes allowed the diver to remove 
equipment and to enter the chamber. In all other cases monitoring was 
performed for a minimum of 5 minutes, and maximum of 20 minutes.
Shunt detection was performed in the Belford Hospital in Fort William 
(courtesy of Dr Gavin Brown, Consultant Physician) as described in 
Chapter 4.
Results
L Shunt detection.
Four divers (4/17) had evidence of right-to-left shunting as detected by 
TCD. Only one diver had shunting at rest, two required the Valsalva 
manoeuvre, and one had shunting only after coughing. Transthoracic 
contrast echocardiography was positive in only one subject following a 
Valsalva manoeuvre and transcranial Doppler ultrasound was positive 
in this subject at rest. In the four subjects with shunting, bubbles were 
detected within five cardiac cycles of the right heart opacifying 
suggesting intracardiac rather than transpulmonary passage of contrast.
2. Dive monitoring.
A total of 73 TCD recordings were made during the study. These are 
described in table 9.2. Sixty-three recordings were made after surfacing 
from dives varying between 16 and 51 metres of sea water (msw). The
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interval between surfacing and monitoring varied between 1.5 and 23 
minutes.
Ten recordings were made in the surface interval before entering the 
decompression chamber. All divers with right-to-left shunting had 
monitoring performed during this interval as it was felt that this was 
the best opportunity of detecting arterial bubbles since the divers had 
still to undergo controlled decompression stops to allow nitrogen to 
leave the peripheral tissues.
Twenty-three (23/73) recordings were undertaken in divers with 
detectable shunting. Monitoring was also performed following a dry 
chamber dive to 50 msw when all subjects had evidence of nitrogen 
narcosis with associated disinhibition and impaired mental function 
similar to that induced by alcohol intoxication. This chamber dive was 
performed as part of the training course to acclimatise the trainees to 
greater depths. The fact that they developed nitrogen narcosis implies 
that a significant amount of nitrogen had been dissolved in the 
peripheral tissues and might be expected to be detected following 
decompression. Monitoring was performed in two of the subjects with 
a PFO following the chamber dive.
Finally monitoring was also performed following an emergency ascent. 
Two divers were taking part in a rescue simulation at depth (45 m) 
when it became clear that the victim was in genuine distress. He did
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not respond to questioning from the surface via an intercom and the 
rescuer in the simulation reported that he had become unconscious. 
The victim was dragged into the diving bell and this was pulled to the 
surface at the maximum rate allowed by the winch mechanical safety 
guard (15 metres/min). Faster ascents cause catastrophic gas bubbling 
and can result in fatal or disabling decompression illness or cerebral 
arterial gas embolism. No breathing was heard over the intercom from 
the diver during the ascent but on surfacing he was able to maintain his 
airway and was able to localise to pain, opened his eyes spontaneously, 
but was disorientated in time, space and person. Emergency 
recompression was started using hyperbaric oxygen, the treatment for 
both carbon dioxide narcosis and also cerebral arterial gas embolism, 
both diagnoses to be considered in this subject. After decompression 
diagnostic TCD monitoring was performed and this revealed bilateral 
increased velocities in the basal cerebral arteries with no evidence of 
gas embolism. These findings supported the clinical diagnosis of 
carbon dioxide narcosis and the diver recovered completely with no 
clinical sequelae. He had developed carbon dioxide narcosis because of 
breathholding to conserve air, a common mistake among inexperienced 
divers. The rescuer in the simulation did well to extend his partner’s 
neck during the ascent thus maintaining a patent airway and avoiding
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the possibility of pulmonary barotrauma with subsequent arterial gas 
embolism.
Despite monitoring a wide variety of dive profiles and subjects, arterial 
ultrasound bubbles were not detected after surfacing in any diver. 
Subjects performed the Valsalva manoeuvre and were asked to cough 
repeatedly to provoke shunting during the monitoring period. 
Technically satisfactory recordings were obtained in all subjects and 
later analysis of stored information failed to reveal any abnormalities.
Discussion
Transcranial Doppler ultrasound has been used successfully to detect 
cerebral emboli in various clinical settings, including carotid artery 
disease, prosthetic valves, and during angiography. These different 
clinical settings are described in detail earlier in Chapter 3. As 
previously discussed, circulating gas bubbles are easy to detect because 
of the large difference in density between the bubble and the 
surrounding blood. It is possible to detect microemboli as small as 30- 
90 pm in diameter.105 The fact that no embolic signals were detected 
strongly suggests that no arterial gas bubbles were present after diving. 
In addition, since artificially introduced gas bubbles were detected 
during the shunt detection investigations, the embolus detection 
technique appeared to work satisfactorily.
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The depths achieved were much greater than most amateur divers 
would attempt since 40 msw is rarely exceeded by air breathing 
amateurs. In addition the dives were longer since the option of surface 
decompression was available. For example, an amateur diver only has 
6 minutes available at 40 msw before incurring decompression 
penalties. Many of the deep dives were for more than 20 minutes and 
included multiple underwater decompression stops. Venous bubbles 
are present in asymptomatic divers after surfacing from depths as little 
as six metres. Spencer detected venous bubbles in 4 of 11 divers 
following a chamber dive to 18 msw for 60 minutes. Dunford et al 
detected venous bubbles in 17% of amateur SCUBA divers after
O'X 1 •surfacing from 6-39 metres. The dives undertaken by the trainees in 
this study were deeper and thus were likely to result in bubble 
formation. We did not monitor for venous bubbles because of technical 
limitations but assumed that they were present in subjects because of 
the depth and duration of the dives.
121The incidence of PFO from autopsy is 20-35% depending on age, 
however the transthoracic echocardiographic incidence in normal 
populations is lower at 5-20%, ’ consistent with only moderate
sensitivity. Our study had an incidence of 6% (1/17) by transthoracic 
contrast echocardiography and 24% (4/17) by transcranial ultrasound. 
This confirms that TCD shunt detection is a more sensitive technique
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than echocardiography, and our experience was that the TCD technique 
was highly suitable for screening healthy individuals in a diving setting 
with no need for hospital equipment or facilities. Contrast 
echocardiography added no additional information and was much more 
difficult to perform, particularly during coughing and Valsalva 
manoeuvres where inflation of the lungs obscured the left atrium and 
septum.
Experimental decompression in pigs with PFO resulted in arterial 
bubbles which were detected immediately prior to surfacing and which 
persisted for over one hour.233'5 The peak bubble incidence was 
between 10 and 30 minutes. The majority of our transcranial 
monitoring was performed at this time (see figure 9.1). The greatest 
pressure change occurs between 10 metres and the surface where 
pressure doubles on diving and halves on ascending (according to 
Boyle’s law). Many cases of arterial gas embolism and decompression 
sickness become apparent during this period.
Bubbles develop preferentially in the venous system because of the low 
ambient pressure. If they cross to the arterial circulation the increased 
pressure may force resolution of the bubbles, hence limiting any 
possible damage. This would help to explain the failure of venous 
bubble counts to correlate with clinical decompression illness. This 
explanation has also been used to explain why the injection of small
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gas bubbles into the venous system during shunt detection has no 
harmful sequelae when detected in the arterial system.
Concerns regarding the long term health of divers have been expressed 
with particular reference to silent bubbles causing subtle neurological
916  917damage with repeated dives. ’ Commercial pressures led to very 
intensive and occasionally dangerous diving practices during the 
1970’s when a form of chronic brain injury was recognised in some 
commercial divers. This involved changes in personality as well as 
objective intellectual impairment. The cause of this chronic damage is 
uncertain but paradoxical gas embolism, high pressure gas toxicity, and 
autochthonous bubble formation all have been implicated. Our initial 
results suggest that arterial bubbles may not be involved since one 
would expect subjects with shunting to have detectable arterial gas 
embolism during dives to the depths achieved during this study. 
However this will have to be confirmed in larger, prospective studies.
This study involved commercial rather than amateur divers. Surface 
decompression has been raised as a potentially risky technique 
available to commercial divers and screening divers for PFO at the 
commercial diving medicals has been suggested. Our results have 
found no evidence of paradoxical embolism during routine diving 
using the United States Naval Decompression Tables, and no evidence
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of gas embolism during the surface interval. This is the first study 
looking for arterial embolism during this period.
We have shown transcranial Doppler ultrasound to be a useful 
technique for screening divers for shunting outwith a hospital setting. 
Portable battery powered machines with liquid crystal displays are now 
available and are suitable for use inside a decompression chamber. 
This would be particularly valuable when treating cerebral arterial gas 
embolism and monitoring the response to recompression. Although 
venous emboli counts have little correlation with the incidence of 
decompression sickness it is possible that arterial counts are more 
specific. Further research is obviously required and TCD monitoring 
will be a suitable technique for this.
Very recent research using MRI scanning has shown an increased 
prevalence of hyperintense subcortical white matter lesions in the 
brains of divers with PFO compared to divers without detectable 
shunting. Divers with multiple brain lesions were found to have 
large PFO. This is concerning since there are over four million certified 
sport divers in the United States and Europe and the consequences of 
chronic paradoxical arterial gas embolism causing brain injury must be 
assessed further. It may be necessary to develop separate 
decompression tables for divers with PFO to minimise the 
development of venous gas bubbles. This would involve routinely
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screening divers for shunting and, if this is to be performed, 
transcranial Doppler ultrasound is the most suitable technique 
available.
Conclusion
Bubbles were not detected in cerebral circulation of commercial air 
divers operating within the recommended decompression limits. The 
presence of right-to-left shunting did not affect these findings.
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Age
(yrs)
Height
cm)
VC
(L)
FVC
(L)
FEV1
(L/sec)
FEF75-85 PEF
(L/min)
25 164 4.33 (4.29) 4.33 (4.29) 3.84 (3.67) 1.56 1.72) 496 (546)
34 187 6.09 (5.95) 6.09 (5.95) 4.67 (4.94) 1.07 1.59) 583(613)
26 175 4.93 (5.18) 5.10(5.18) 4.53 (4.37) 1.83 1.77) 626 (583)
2 1 195 6.45 (6.18) 6.69 (6.18) 4.84 (5.36) 1.77 2 .1 1 ) 417(660)
29 180 5.50 (5.51) 5.47 (5.51) 4.05 (4.62) 0 . 8 6 1.71) 460 (596)
24 173 5.29 (5.11) 5.47 (5.11) 4.52(4.41) 1.08 1.83) 658 (579)
28 180 5.69 (5.54) 5.81 (5.54) 5.08 (4.65) 1.69 1.74) 610(598)
23 182 5.26 (5.56) 5.31 (5.56) 4.61 (4.81) 1.80 1.93) 624 (612)
23 163 4 . 4 9  (4 .4 4 ) 4.53 (4.44) 3.85 (3.81) 1.13 1.78) 572 (546)
24 183 6.62 (5.69) 6.71 (5.69) 5.75 (4.93) 2.31 1.91) 712(613)
28 176 5.33 (5.21) 5.66 (5.21) 4.67 (4.38) 1 . 2 0 1.71) 695(583)
29 170 5.72 (4.67) 6.00 (4.67) 4.66 (3.96) 1 . 2 0 1.63) 625 (561)
2 1 191 6.95 (6.24) 6.97 (6.24) 5.82 (5.41) 2 . 0 0 2.07) 837 (640)
31 184 6.28 (5.79) 6.08 (5.79) 5.64 (4.83) 3.05 1.67) 765(607)
2 1 183 5.15 (5.47) 5.06 (5.47) 4.56 (4.74) 2.41 2 .0 1 ) 562 (618)
31 179 5.18(5.37) 5.24 (5.37) 4.40 (4.49) 1.77 1.63) 513 (590)
28 186 5.76 (6.05) 5.78 (6.05) 4.82 (5.05) 1.50 1.79) 817(618)
2 2 197 6.47 (6.37) 6 . 6 6  (6.37) 5.49 (5.53) 5.77 2.09) 764 (665)
Table 9.1
Subject characteristics including spirometry with predicted values in 
parentheses.
Key to abbreviations: VC= vital capacity, FVC= forced vital 
capacity, FEV1= forced expiratory volume in 1 second, F E F  
7 5 -8 5  = forced expiration fraction from  75 to 85% o f  FVC,
PEF= peak expiratory flow.
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Table 9. 2.
Dive characteristics in 17 subjects undergoing transcranial 
Doppler monitoring.
Diver Shunt Depth
(msw)
Time
(min)
Decompression
(msw)
13 10 6.7
stops
3.3
Total Gap
(min)
TCD
(min)
Surface
Decom­
pression
1 Yes 16 50 - - 15 65 16 5 No
29 40 - - 5 45 16 5 No
31 23 - - - 25 2 1 2 0 No
31 30 - - 15 45 5 5 Yes*
2 Yes 16 50 - - 15 65 2 0 5 No
19 40 - - 5 45 1 2 5 No
31 23 - - - 25 19 2 0 No
31 30 - - 15 80 1 5 Yes*
3 No 16 50 - - 1 0 60 1 2 5 No
19 40 - - 5 45 13 5 No
31 23 - - - 25 19 2 0 No
31 30 - - 15 45 1 5 Yes
50 6 - - - 2 1 1 0 5 Chamber
dive
4 Yes 16 50 - - 1 0 60 8 5 No
25 43 - - 1 2 56 1 0 5 No
31 23 - - - 26 13 2 0 No
18 65 - - 15 80 5 5 *Yes
50 5 - - - 2 1 1 0 5 Chamber
dive
5 No 17 40 - - 5 45 8 5 No
23 40 - - 5 45 19 5 No
31 23 - - - 25 1 0 2 0 No
31 30 - - 15 45 7 5 Yes
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Diver Shunt Depth
(msw)
Time
(min)
Decompression
(msw)
13 10 6.7
stops
3.3
Total Gap
(min)
TCD
(min)
Surface
Decom­
pression
6 Yes 17 40 - -  ' - 5 45 8 5 No
23 45 - - - 5 50 23 5 No
31 25 - - - 5 31 18 5 No
31 27 - - - 18 45 2 5 Yes*
50 5 - - - - 2 1 1 0 5 Chamber
dive
7 No 18 40 - - - 5 45 7 5 No
2 1 43 - - - 1 2 56 15 5 No
31 23 - - - - 25 14 2 0 No
32 29 - - - 30 60 1 0 5 Yes*
8 No 18 40 - - - 5 45 5 5 No
24 43 - - - 15 59 14 5 No
31 23 - - - - 25 13 2 0 No
31 29 - - - 30 60 1.5 5 Yes*
50 5 -■ - - - 2 1 1 0 5 Chamber
dive
9 No 18 40 - - - 1 0 50 15 5 No
24 43 - - - 15 59 1 2 5 No
31 23 - - - - 25 11 2 0 No
31 27 - - - 18 45 3 5 Yes
1 0 No 47 30 - 7 2 0 34 91 1 0 5 No
37 30 - - 9 25 65 11 5 No
48 25 8 7 - - 42 2 5 4eYes
11 No 47 30 - 7 2 0 34 91 15 5 No
47 28 - 7 19 14 89 1 0 5 No
50 25 6 1 0 - - 42 5 5 Yes
Table 9.2 (continued)
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Diver Shunt Depth
(msw)
Time
(min)
Decompression stops 
(msw)
13 10 6.7 3.3
Total Gap
(min)
TCD Surface 
(min) Decom­
pression
1 2 No 47 19 - - 1 0 25 54 1 0 5 No
47 2 0 - - 1 0 25 55 11 5 No
51 2 0 8 7 - - 36 2 5 afcYes
13 No 47 19 - - 1 0 2 2 55 5 5 No
47 2 0 - - 1 0 25 55 8 5 No
51 2 0 8 7 - - 36 1 5 Yes
14 No 47 2 0 - - 1 0 2 2 55 5 5 No
47 2 0 - - 9 25 54 14 5 No
48 2 0 6 - - - 27 5 5 Yes
15 No 47 2 0 - - 1 0 2 2 55 1 0 5 No
47 2 0 - - 9 25 54 1 2 5 No
48 2 0 6 - - - 27 1 5 Yes*
16 No 47 2 0 - - 11 25 55 1 0 5 No
47 18 - 9 - - 28 2 5 Yes
45 11 - - - - 15 5 5 * *Yes
17 No 47 2 0 - - 11 25 55 1 0 5 No
47 18 - 9 - - 28 1 1 5 Yes
Table 9.2
Depth is the maximum achieved during the dive in msw, Time 
is the bottom time in minutes, Gap is the interval between 
surfacing and transcranial monitoring, and Total is the dive 
duration including bottom time, the decompression stops and 
the time required fo r  surfacing. TCD is the duration o f  
transcranial Doppler monitoring in minutes.
* Monitoring performed during the surface interval as well as 
after leaving the chamber.
** Emergency ascent with monitoring performed after leaving 
chamber.
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Figure 16
Time distribution of TCD recordings after surfacing.
N um ber of recordings
35 
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5 
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5 15 25 35
Time after surfacing (minutes)
■  Divers without shunting 
□  Divers with positive PFO screen
This graph shows that most o f the TCD recordings were performed 10-20 minutes 
after surfacing when the peak incidence o f arterial bubbling might be expected 
according to animal models (see text). The graph plots the number o f subjects 
being monitored at the time specified. For example, a monitoring session starting 5 
minutes after surfacing and lasting for 1 0  minutes will be included in each o f the 
bars from 5 to 15 minutes.
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CHAPTER 10 TRANSCRANIAL DOPPLER
Embolus detection in carotid atherosclerosis 
Introduction
The increasing awareness of hypertension and its effective treatment 
has been associated with a decline in the incidence of stroke,
I nQ
particularly in North America. The major benefit of treatment has 
been a reduction in the incidence of haemorrhagic and lacunar strokes
17Q #rather than those due to atherosclerosis. With this relative change in 
stroke causation there has been a relative increase in stroke due to large 
vessel atherosclerosis and cerebral embolism. There are several 
potential sources of cerebral embolism in the genesis of acute stroke, 
including valvular heart disease, high grade (>70%) internal carotid 
artery stenosis, acute myocardial infarction, intracardiac thrombus and 
atrial fibrillation. In addition, recent work suggests a link between 
plaques in the thoracic aorta, particularly if there is evidence of plaque 
ulceration or haemorrhage; and mitral annular calcification in the 
elderly240 is associated with an increased risk of stroke.
Carotid atherosclerosis is common. Intimal-medial thickening is 
present in over 50% of the general population over the age of 50 years, 
and non-stenotic plaque can be found in between 20-50% of those over
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the age of 60 years.241,242 Up to 10% of those over the age of 65 years, 
and up to 30% of those attending hospital with peripheral or coronary 
artery disease, have greater than 50% stenosis of one carotid 
artery.243,244
The indications for carotid endarterectomy remain controversial. While 
symptomatic patients with severe (>70%) stenosis of the internal 
carotid artery benefit from surgery with a 75% reduction in rate of 
stroke in the subsequent two to three years,245,246 selection criteria for 
asymptomatic patients are less certain. There was little evidence in 
favour of surgery in asymptomatic patients until the interim results 
from the Asymptomatic Carotid Atherosclerosis Study247 (ACAS) were 
published in 1994. The National Institute of Neurological Disorders 
and Stroke halted this study because asymptomatic patients with 
carotid stenosis (>60%) were found to benefit from endarterectomy. 
They found a 5.8% absolute risk reduction in the risk of stroke (relative 
risk reduction 55%) but were careful to remind physicians that 
endarterectomy should be recommended only after careful patient 
selection and performed by surgeons with a documented perioperative 
mortality and morbidity of less than 3%.
With these developments in surgical selection and the change in 
pattern of cerebrovascular disease there is a growing need to identify 
patients who could benefit most from carotid endarterectomy.
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Transcranial Doppler (TCD) ultrasound has been used to identify 
microembolic signals in patients with carotid artery disease (as 
reviewed earlier in Chapter 3) but the specificity of the technique has 
yet to be assessed. One concern is the underlying nature of the signals. 
If they were found to be present in patients with atherosclerotic plaque 
but without haemodynamically significant stenosis then their clinical 
use would be severely limited.
ACAS Study
TCD embolus counting has been described in patients with carotid 
atherosclerosis but studies so far have concentrated on patients with 
high grade stenosis (>70%) of the internal carotid artery. This is logical 
since such patients are at risk of embolic stroke.249 Microembolic 
signals are present in 20% of patients with high grade stenosis and are 
more common in individuals with a recent neurological event affecting
•  in « •the ipsilateral hemisphere. ' The incidence in asymptomatic patients 
is similar to that of silent cerebral infarction detected by computed 
tomography in various small studies (6% to 29%) and matches the 
incidence found in the much larger baseline assessment of the ACAS 
patients. This was a study of 848 asymptomatic patients who were 
assessed and examined by neurologists to exclude any history or 
clinical evidence of a neurological deficit. Patients were aged 40-79
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years and had unilateral or bilateral surgically accessible stenosis of the 
common or internal carotid artery as measured by carotid ultrasound 
and confirmed by invasive angiography in cases randomised to surgery. 
All patients had computed tomography (CT) scans of the brain at 
baseline which were examined for evidence of silent cerebral 
infarction. Of the 848 eligible patients, 126 (15%) had evidence of 
silent cerebral infarction with the majority (95) having a single infarct. 
However 24 patients had 2 silent infarcts and 7 patients had 3 or more. 
The majority (117) were small and deep but 45 were up to one half 
lobe in size. There was no relation between the severity of carotid 
stenosis and the prevalence of infarction. The link between subclinical 
infarction and subsequent clinical events is still tenuous, although there 
was evidence suggesting impairment of mental function associated 
with infarction. These results confirm that subclinical embolism does 
occur in carotid artery stenosis and suggest that TCD embolus counting 
may help to identify the individuals most at risk.
If TCD embolus counting is to be clinically useful then it is necessary 
to study patients across the full range of carotid disease. It is not yet 
known if signals are present in patients without severely stenosed 
arteries, or even in normal individuals. The cause of the signals in 
carotid artery disease is still unclear and several possible mechanisms 
have been suggested. Turbulent blood flow through a stenosed artery
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may cause aggregation of platelets or leukocytes and these clumps 
could cause signals. There may be eddies or areas of stasis distal to the 
stenosis which result in activation and adhesion. Another possibility is 
that atherosclerotic plaque directly activates platelets or leukocytes. If 
this occurs then it would reduce the specificity of TCD embolus 
counting when identifying patients at risk of embolic stroke.
The aim of this study therefore was to compare patients with normal 
carotid arteries to those with atherosclerotic plaque. In addition a small 
number of patients with high grade stenosis of the internal carotid 
artery were studied to confirm the sensitivity of the technique.
Methods
All subjects gave informed consent for their participation in this study 
which had local Ethics Committee approval. Subjects were recruited 
from the cardiovascular risk factor outpatient clinics and were aged 45- 
75 years, not anticoagulated and had no history of cardiac or carotid 
surgery, or angioplasty. They had not experienced a neurological event 
within 12 months of the study. Other possible sources of embolism 
were excluded by clinical examination and transthoracic 
echocardiography. These included atrial fibrillation, significant aortic 
or mitral valve disease, mitral annular calcification or left ventricular 
dysfunction.
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TCD monitoring was performed as described in chapter 4. The carotid 
arteries were examined by conventional Duplex scanning using an 
Acuson 128 (Acuson, Mountain View, California) with a 7.5 MHz 
probe as described in chapter 4. The severity of carotid stenosis was 
calculated according to the ratio of the internal to the common carotid 
artery velocities, and the presence of spectral broadening, according to
17 n  7^1recognised criteria. ’ In addition high resolution B-mode scanning 
was performed using a Biosound 2000 II SA system as described in 
chapter 4. This allowed more detailed imaging of the arterial wall and 
accurate detection of atherosclerotic plaque. Plaque was defined as a 
focal area of intima-medial thickening (see chapter 4). All 
examinations were recorded on video tape and analysed independently 
of the TCD data by two observers. Carotid atherosclerosis therefore 
was staged as: (1) normal, (2) intima-medial thickening (IMT group), 
(3) plaque but stenosis less than 70% and (4) stenosis >70%.
The split between normal and intimal-medial thickening was made 
statistically once all video tapes had been analysed (see below)
Results
The clinical characteristics of the 161 study subjects are presented in 
table 10.1 (below). The most significant differences between groups 
were of age (higher in the plaque group), blood pressure and weight
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(higher in the normal group), creatinine (highest in the stenosis group 
but no significant difference between the remaining groups) and 
haematocrit (lowest in the IMT group). In addition, fibrinogen levels 
correlated well with carotid atherosclerosis severity (see figure 17).
Ultrasound analysis
The two observers agreed on the classification of carotid disease in all 
cases. The majority of subjects (94%) had normal arteries or evidence 
only of plaque without stenosis. The mean intima-medial thickness for 
the entire study population without plaque or stenosis was 0.643 and 
this level was used to statistically divide classify subjects into normal 
wall thickness (^0.643 mm) and or increased wall thickness (>0.643 
mm) groups.
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N orm al IM T Plaque Stenosis P
M ale/fem ale 20/24 51/26°* 18/22 6/4 <0.05*
Age (years) 57 ± 8 59 ± 8 62*± 8 68 ± 5 0.031
B lood pressure 160 ±  18 170° ± 2 2 153 ± 2 0 153 ± 2 1 0.001
(m m H g) 104 ± 12 105 ±  11 98*° ± 1 5 84 ± 6 0.022
H eight (cm) 170 ± 9 171 ± 7 166 ± 9 169 ± 9 0.186
W eight (kg) 81 ±  15 85 ± 15 74° ±  16 70 ±  13 0.045
y GT (u/1) 43 ± 3 5 47 ± 5 1 42 ± 6 3 62 ± 9 3 0.862
C reatinine (pmol/1) 83 ±  15 87 ± 2 1 85 ±  19 125 ± 6 4 0.611
G lucose (mmol/1) 5 .6 ±  1.3 5.3 ± 0 .8 5.3 ± 0 .7 5.8 ± 0 .7 0.212
C holesterol (mmol/1) 6.1 ± 1.0 5.8 ± 0 .9 5.9 ±  1.0 6.2 ± 1.6 0.350
Triglycerides(m m ol/l) 1.74 ± 0 .9 9 1.66 ± 1.04 1.63 ± 0 .8 0 1.67 ± 1.04 0.861
H aem atocrit 0 .40 ±  0.09 0.34*° ±  0.17 0.41 ± 0 .0 7 0.29 ±  0.20 0.009
Fibrinogen (u/1) 274 ± 63 319*±87 330* ±  79 420 ± 97 0.004
Lipoprotein (a) 24.3 ± 23.9 28.0 ± 3 4 .1 34.4 ±  36.2 43.0 ± 3 5 .7 0.361
Table 10.1 Patient characteristics (mean ± SD)
Note: statistical comparison is between normal, intimal-medial 
thickening (IMP) and plaque groups. The stenosis group is excluded 
from  comparison because o f  the smaller population size.
test, csignificant difference between plaque and IM T group, 
* significant difference compared to normal
156
600 n
500 -
100  -
P la q u e  S t e n o s i sN orm al IMT
Figure 17. Fibrinogen and carotid atherosclerosis severity.
♦significant difference compared to normal. Stenosis group 
highlighted to exclude from statistical comparison because of smaller 
sample size (see text).
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Seventeen subjects had a history of stroke or transient ischaemic 
attack and the highest prevalence was in the stenosis group (5 of 10 
subjects compared to 2, 0 and 10 for the normal, IMT and plaque 
groups respectively). All of these events occurred more than one year 
prior to the study with the majority occurring between 2 and 10 years 
before recruitment.
Four of the ten patients with >70% stenosis of the internal carotid 
artery had microembolic signals (see figure 18). The mean rate of 
embolism was 14 per hour (range 2-18) and all signals were detected 
in the middle cerebral artery ipsilateral to the stenosed carotid artery. 
The two observers agreed in the classification of all but one 
microembolic signal which was excluded from analysis. This did not 
alter the number of subjects with detectable signals. All four patients 
with detectable microembolic signals were taking regular aspirin (75 
to 300 mg per day).
No signals were detected in the other patient groups. It was not 
possible to monitor the middle cerebral artery in two patients with 
normal carotid arteries because of temporal hyperostosis, a recognised 
limitation of the TCD technique. All other subjects had adequate 
temporal windows. No subject had evidence of plaque ulceration or 
intraplaque haemorrhage.
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Figure 18. Example of microembolic signal
The embolus signal (arrowed) appears red on the background of the 
arterial waveform (blue) because of the high intensity. It is of short 
duration and appears above the baseline only whereas artefact causes 
bidirectional signals. The signal is associated with a characteristic 
audible chirp.
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Discussion
The principal finding of this study is the absence of microembolic 
signals in patients with internal carotid artery atherosclerotic plaque. 
The sensitivity of transcranial Doppler ultrasound monitoring was 
confirmed by the detection of microembolic signals in the high grade 
stenosis patients.
Plasma fibrinogen levels correlated well with the severity of carotid 
artery disease and are known to reflect cardiovascular morbidity and 
mortality. ' The increase in fibrinogen suggests that the 
atherosclerotic changes in vascular endothelium influence plasma 
thrombotic potential and the highest levels of fibrinogen were seen in 
the high grade stenosis group. Turbulent blood flow appears to be 
relevant in the development of microembolic signals since none were 
detected in the patients with atherosclerotic plaque and no turbulence.
'j cr\
The ACAS study results pose a significant clinical problem. Only 
10.6% of the medically treated patients in this study had an embolic 
stroke related to their carotid disease compared with 4.8% of those 
randomised to surgery. Carotid endarterectomy itself has a small but 
significant risk. Although the accepted perioperative morbidity and 
mortality rate is less than 3%, the absolute risk reduction regarding 
embolic stroke is only 5.8%. In addition invasive angiography also had
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an appreciable risk with 1.2% of the ACAS patients having a stroke
' yn
precipitated by this investigation. In addition, a study of ten year 
cerebrovascular morbidity and mortality of men with asymptomatic 
carotid artery stenosis found no significant increase in the incidence of 
stroke. This was thought to be due to a high incidence of death from 
myocardial infarction.
Thus there are difficulties for the clinician in deciding whether to treat 
asymptomatic individuals medically or whether they should be 
referred for surgery. If individuals could be stratified in terms of risk 
then the overall risk reduction would be much greater and the 
corresponding benefit to risk ratio would be higher. The severity of 
carotid stenosis did not add any prognostic information. There are no 
convincing means of doing this at present although TCD embolus 
counting theoretically may be suitable. The argument for this is 
detailed below.
This study confirms that microembolic signals detected by TCD are 
specific to patients with high grade stenosis of the internal carotid 
artery. TCD embolus counting was largely discounted as a clinical tool 
partly because of the concept of silent embolism. Original studies of 
patients with prosthetic cardiac valves demonstrated many hundreds of 
signals per hour with no objective neurological impairment as 
described earlier. However recent work suggests that they may be
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caused by gaseous cavitation during valve leaflet closure.98,116 Carotid 
signals are different entirely; they tend to be less frequent and have 
different characteristics suggesting that they may be caused by 
particulate matter. Circumstantial evidence for a clinical correlation 
was provided by the rate of silent cerebral infarction detected by 
computed tomography in the ACAS patients. This was almost 
identical to that of microembolic signals detected by TCD.
TCD microembolic signals are specific to individuals with high grade 
internal carotid artery stenosis. They do not occur in patient with 
atherosclerotic plaque alone. The next step must be to study the 
relation of signals to clinical endpoints including stroke in a large 
prospective study. Background work has been performed which 
confirms high levels of reproducibility and inter-centre agreement in
' J C ' J
the classification of microembolic signals in carotid artery disease, 
thus it is technically possible to perform a multicentre study which 
will be essential to provide the high numbers of patients required.
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CHAPTER 11 CONCLUSIONS
The studies described in this thesis have used different ultrasound 
approaches to examine various aspects of the cardiovascular system, 
but all depend on the common principle of detection of reflected 
ultrasound energy which first was used in divers during the 1960’s. 
Ultrasound is now used frequently in clinical practice to image almost 
every organ within the body and to study both structure and function. It 
has become the imaging modality of choice in many areas despite the 
advent of new radiological methods including high resolution and 
spiral computed tomography scanning. Magnetic resonance imaging 
may well supersede ultrasound in the future in some areas but is 
unlikely to become a rival in terms of convenience, portability, expense 
or availability. One of the main attractions of ultrasound is the 
opportunity to repeat scans without concern of radiation hazard which 
is significant with most other imaging techniques (apart from magnetic 
resonance imaging). Emphasis is now shifting from measurement of 
structural abnormalities to the early detection of more subtle 
dysfunction in an effort to prevent potentially harmful structural 
responses, for example left ventricular hypertrophy. This has led to the
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involvement of ultrasound in morbidity and mortality studies although 
only recently have some of the functional abnormalities been linked to 
clinically significant events. Examples include the detection of left 
ventricular diastolic dysfunction which may be related to the future 
development of clinically significant systolic dysfunction. There is 
increasing pressure to use ultrasound as a way of detecting clinically 
silent abnormalities in an effort to increase the effectiveness of 
treatment and to select individuals who are at high risk of clinical 
events and thus could benefit most from intervention. The investigation 
of disease prevention or progression requires large studies involving 
hundreds or thousands of patients and demands long follow-up periods 
if mortality benefits are to be detected. Surrogate endpoints of clinical 
events, such as the measurement of arterial wall thickness or 
atherosclerosis severity, may give an earlier indication of effectiveness 
of treatment and thus reduce patient numbers and follow-up 
requirements.
This approach is the basis of the studies described in this thesis which 
concentrates on the ultrasound techniques applicable to cardiovascular 
medicine, in particular echocardiography, vascular compliance 
measurement by high resolution A-mode ultrasound and pulsed wave 
Doppler sampling, structural measurement by high resolution B-mode
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ultrasound and embolus detection using fast Fourier transformation of 
continuous wave low frequency Doppler ultrasound (as transcranial 
Doppler). These are the main approaches available at present. The 
study involving divers was particularly attractive since it involved 
using the most modem ultrasound technology in the group of subjects 
first studied by ultrasound in medicine.
White coat hypertension
The study of white coat hypertension included the assessment of 
cardiac structure by M-mode echocardiography and diastolic function 
using pulsed wave Doppler ultrasound before linking these 
measurements to carotid arterial compliance parameters obtained by A- 
mode ultrasound. White coat hypertension is a well recognised clinical 
problem which, for the majority of physicians, continues to be regarded 
as a reason not to start treatment or undertake investigation. One 
reassuring aspect of the results was the absence of left ventricular 
hypertrophy in the white coat hypertensive group and this indicates that 
their longterm cardiovascular mortality should not be as high as the 
persistent hypertensive group. The main conclusion is that such 
patients should not be ignored and that further large scale studies of the 
white coat response were required to measure the benefits of treatment.
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The study was designed to include the possibility that the white coat 
response might interfere with the functional measurements being 
assessed hence the multiple calculated parameters of vascular 
mechanics which were detailed in chapter 2. Many white coat 
hypertensives develop sustained hypertension (75% in a recent
1 STstudy ) and this progression could not be predicted on the office 
blood pressure. Such progression is more common in elderly women 
and might be related to the loss of cardiovascular protection following 
the menopause. It is interesting that the white coat response is resistant 
to treatment and it may become necessary to use alternative measures 
of cardiovascular risk in these patients such as the presence of 
microalbuminuria, left ventricular hypertrophy or, more 
controversially, diastolic dysfunction and abnormal arterial 
compliance. These issues all need to be addressed in future research 
which is likely to require very long term morbidity and mortality 
studies to assess the effects of treatment and the effectiveness of 
surrogate endpoints in predicting clinical events.
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Carotid arterial pulsatility
The study of carotid arterial pulsatility by Duplex ultrasound illustrated 
an alternative approach to the measurement of vascular function. 
Duplex ultrasound is used frequently in clinical practice to measure 
stenosis by the increase in blood flow velocity which results when 
blood is forced through a vessel of reduced lumen. Further analysis of 
the blood flow velocity waveform is possible and this allows the 
mechanical stretching forces to be estimated within the artery and its 
distribution territory. Clinically it is unclear why the treatment of 
hypertension has had a much greater impact on the incidence and 
complications of cerebrovascular disease compared to ischaemic heart 
disease. One possibility suggested by Spence176 is explored in detail in 
chapter 7 where the beneficial effect of antihypertensive therapy on the 
incidence of haemorrhagic stroke has been well described and 
contrasted with a more disappointing effect on atherosclerotic 
cerebrovascular disease. This has resulted in a change in the pattern of 
cerebrovascular disease now presenting to clinicians. The study 
described in chapter 7 offers some supporting scientific evidence to 
show that hypertension is associated with significantly increased 
mechanical strain within the internal carotid artery and its distribution
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area. The effects of treatment now require further study although 
preliminary work by other researchers using Doppler ultrasound has 
shown favourable changes in carotid flow patterns dependent on the 
level of blood pressure reduction. Such ultrasound abnormalities reflect 
subclinical cerebrovascular strain and should be assessed in longterm 
clinical studies of antihypertensive therapy and cerebrovascular 
disease. The mechanical strain suggested by this technique may simply 
occur during periods of hypertension but also may be exacerbated by 
structural changes within the cerebrovascular system similar to the 
adverse effects of early wave reflection on diastolic left ventricular 
function as described earlier. Further research using blood flow 
velocity will soon be possible using instruments which allow 
simultaneous continuous measurement of arterial diameter and blood 
flow velocity. This also allows direct estimation of blood flow in 
mls/min. The differential effects of the various classes of 
antihypertensive medication will require to be studied and it will be 
necessary to link the ultrasound abnormalities to clinical endpoints so 
that future studies can use the ultrasound surrogate markers to save 
time, money and, most importantly, reduce patient morbidity and 
mortality.
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Carotid arterial structure
The various functional assessments discussed above are affected by 
ambient physical conditions, such as blood pressure, and can be 
influenced by medication, diurnal variation, temperature or stress. This 
emphasises the need for rigorous control of the clinical environment 
and standardisation of patient examination to eliminate such 
variability. The satisfactory coefficient of variations for 
echocardiographic and compliance measurements indicates that this 
can be and was achieved. Measurement of the structural abnormalities 
does not suffer from such restrictions provided care is taken to 
standardise the methodology, for example when measuring left 
ventricular structure, or arterial wall thickness. High levels of training 
were required for the sonographers to perform scientifically 
reproducible carotid B-mode examinations and then detailed quality 
control was employed to allow accurate off-line measurement of 
carotid wall thickness. The finding of increased arterial wall thickness 
in white coat hypertensives is of clinical concern since such wall 
thickening is now regarded as an early sign of target organ damage 
reflecting a systemic structural response to the stress of hypertension.
1 q / \
A recent conference on arterial wall thickening set out to define IMT
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as a putative risk factor in cardiovascular disease and this confirmed 
the great potential for non-invasive monitoring of arterial wall 
thickening in hypertension, hyperlipidaemia, and cardiac failure. 
Arterial wall thickness is a risk factor which is known to be linked with 
arterial disease elsewhere and the association with clinical events is 
becoming firmer. However, while treatment of the various conditions 
that cause arterial wall thickening (eg antihypertensive therapy, lipid 
lowering therapy, or vasodilators in cardiac failure) reduces morbidity 
and mortality, the association with changes in arterial wall thickness 
remains to be proven. This is the underlying hypothesis behind several 
large scale trials of antihypertensive therapy, and has already been 
proven in hyperlipidaemia. Therefore the finding of increased arterial 
wall thickness in white coat hypertensives is significant and the 
intermediate value between normotensives and persistent hypertensives 
is consistent with the estimated clinical risk of white coat hypertension. 
Arterial wall thickening was shown to be a very early sign of end organ 
damage since there was no evidence of left ventricular hypertrophy or 
of renal impairment in the white coat hypertensives. Once again large 
scale studies are required to validate this approach and there is a need 
to examine cohorts of white coat hypertensives defined in terms of 
detectable structural and functional abnormalities as described above
170
over a longterm clinical follow up to determine the links and predictive 
value for clinical events.
Embolus detection
This approach was adopted in the 1960’s for Doppler embolus 
detection after initial studies used the new technique to detect bubble 
signals in decompressing divers. The significance of the signals was 
unclear so the researchers moved on to larger studies to examine 
subjects after dives of varying severity in terms of depth, duration, 
temperature and workload. Unfortunately there was a poor correlation 
between the bubble signals and the clinical events associated with 
decompression sickness although there were significant technical 
limitations at the time (ultrasound signals were only analysed as 
audible tones). Technology has advanced considerably since then and it 
is now possible to view the Doppler waveform by fast Fourier 
transformation as shown in figure 18. It is now possible to detect more 
subtle embolic signals and work continues to determine their link with 
the incidence and severity of decompression sickness. Using the 
relatively new technique of transcranial Doppler ultrasound the study 
described in chapter 9 was the first published study to examine the 
cerebral circulation of divers during decompression and to specifically
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screen for right-to-left shunting. This has become increasingly topical 
since the number of recreational divers is increasing rapidly world­
wide and interest has again focused on the possibility of silent 
paradoxical embolism as a cause of cerebral damage and increased 
susceptibility to decompression sickness. Notably a very recent 
study238 found evidence of lesions within the brains of divers with 
patent foramen ovale. This issue was raised by the Health and Safety 
Executive in the UK and the possibility of screening divers for PFO 
before allowing commercial training was considered. A previous 
problem was the lack of a suitable non-invasive screening test which is 
now possible with transcranial Doppler ultrasound as described earlier. 
While the results of the study in Chapter 9 are reassuring there remain 
several unanswered questions which could be addressed in a 
prospective study involving a large cohort of divers with shunting, 
comparing the incidence and severity of decompression sickness to 
matched controls, examining for more subtle forms of neurological 
damage by psychometric testing, and screening for CNS lesions by 
magnetic resonance imaging. A further potential study could lead to the 
development of a decompression table determined by venous and 
arterial bubble counts, including limits specifically for subjects with 
PFO. It may be possible to develop no-bubble tables that minimise the
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risk of paradoxical embolism and transcranial Doppler ultrasound may 
be useful for this. These studies are already being considered by the 
regulatory authorities in the UK and abroad including the Divers Alert 
Network based in Duke University, North Carolina. Preliminary 
discussions with the Scottish Sub-Aqua Club are underway to initiate 
the research with the support of the UK Sport Diving Medical 
Committee.
The final study described the search for more elusive microembolic 
signals in carotid atherosclerosis which potentially could be used to 
identify high risk individuals with asymptomatic internal carotid artery 
stenosis. This preliminary work is essential to determine the specificity 
of microembolic signals in carotid atherosclerosis since larger studies 
are soon to be carried out evaluating the predictive value of 
microembolic signal counts in high grade stenosis.
Overall the research described in this thesis has confirmed the value of 
the various ultrasound techniques in each of the different clinical 
settings. The common theme was the detection of pre-clinical markers 
of potentially harmful disease processes. Large longterm follow-up 
studies are already evaluating the predictive value of such surrogate 
markers, and determining the effects of treatment or behaviour 
modification. The versatility of ultrasound in medicine is obvious and
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already has been of great value. This thesis has identified further roles 
which require additional research. No doubt there will be further 
technical advances that will continue to expand future clinical 
applications.
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Appendix A
List of abbreviations
p Density of blood
y-GT Gamma glutaryl transferase
A dec Deceleration time for active / atrial ventricular filling
ABPM Ambulatory blood pressure monitoring
ACAS Asymptomatic carotid atherosclerosis study
ACE Angiotensin converting enzyme
ANOVA Analysis of variance
ARIC Atherosclerosis risk in communities study
BMI Body mass index
BP Blood pressure
Cl Confidence interval
CT Computed tomography
dB Decibels
DC Distensibility coefficient
Dd Diastolic (minimum) diameter
Ds Systolic (maximum) diameter
E Young’s elastic modulus
E dec Deceleration time for early left ventricular filling
E:A Ratio of early and late ventricular filling velocities
ELSA European lacidipine study on atherosclerosis
Ep Peterson’s pressure-strain elastic modulus
FEF 75-85 Forced expiratory fraction (from 75 to 85%)
FEV1 Forced expiratory volume in one second
FVC Forced vital capacity
h Arterial wall thickness
IMT Intima-medial thickness
IVRT Isovolumetric relaxation time
IVSd Interventricular septal thickness in diastole
IVSs Interventricular septal thickness in systole
IVST Interventricular septal thickness
Ln Natural logarithm
Lp(a) Lipoprotein (a)
LV Left ventricle
LVEDD Left ventricular end diastolic diameter
LVESD Left ventricular end systolic diameter
LVM Left ventricular mass
LVPWd Left ventricular posterior wall thickness in diastole
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Appendix A
List of abbreviations (continued)
LVPWs Left ventricular posterior wall thickness in systole
MHz Megahertz
msw Metres sea water
NS Not significant
PEF Peak expiratory flow rate
PFO Patent foramen ovale
PI Pulsatility index
PWT Posterior wall thicknes
PWV Pulse wave velocity
R Outer radius
SCUBA Self contained underwater breathing apparatus
SD Standard deviation
SHEP Systolic hypertension in the elderly programme
TCD Transcranial Doppler
VC Vital capacity
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List of abstracts and publications
1. Paradoxical cerebral embolism in divers. Glen SK, Georgiadis D, Grosset DG, 
Douglas JDM, Lees KR. Abstract presented at the National Transcranial Doppler 
Conference in Leicester, UK (June 1994)
2. Monitoring of anticoagulation by transcranial Doppler. Glen SK, Grosset DG, 
Lees KR. Lancet 1995;345:57-58 (letter)
3. Carotid wall morphology and cerebral embolism. Glen SK, Grosset DG, Curzio J, 
Hillis WS, Lees KR, Elliott HL, Reid JL. Abstract presented at the European 
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4. Cerebral embolism in carotid atherosclerosis. Glen SK, Grosset DG, Curzio J, 
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1995) Stroke 1995;731 (abstract)
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